@prefix : <http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy> .
@prefix dc: <http://purl.org/dc/elements/1.1/> .
@prefix mp: <http://purl.org/mp/> .
@prefix oa: <http://www.w3.org/ns/oa#> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix core: <http://purl.obolibrary.org/obo/uberon/core#> .
@prefix foaf: <http://xmlns.com/foaf/0.1/> .
@prefix pato: <http://purl.obolibrary.org/obo/pato#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix core1: <http://purl.obolibrary.org/obo/core#> .
@prefix terms: <http://purl.org/dc/terms/> .
@prefix uberon: <http://purl.obolibrary.org/obo/uberon#> .
@prefix subsets: <http://purl.obolibrary.org/obo/ro/subsets#> .
@prefix oboInOwl: <http://www.geneontology.org/formats/oboInOwl#> .
@prefix OpenPVSignal: <http://purl.org/OpenPVSignal/OpenPVSignal.owl#> .
@base <http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy> .

<http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy> rdf:type owl:Ontology ;
                                                                          owl:imports <http://purl.org/OpenPVSignal/OpenPVSignal.owl> ,
                                                                                      mp: ;
                                                                          rdfs:isDefinedBy "https://apps.who.int/iris/handle/10665/255511/"^^xsd:anyURI ;
                                                                          rdfs:label "Dronedarone and vision abnormal"^^xsd:Literal ;
                                                                          owl:versionInfo "draft-v0.95-20211112"@en .

#################################################################
#    Object Properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element
OpenPVSignal:Free_text_reporting_element rdf:type owl:ObjectProperty .


###  http://purl.org/mp/references
mp:references rdf:type owl:ObjectProperty .


#################################################################
#    Data properties
#################################################################

###  http://purl.org/mp/citation
mp:citation rdf:type owl:DatatypeProperty .


#################################################################
#    Individuals
#################################################################

###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#AcetylsalicylicAcid
:AcetylsalicylicAcid rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug ;
                     OpenPVSignal:has_ATC_code "B01AC06" ;
                     rdfs:label "acetylsalicylic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#DIONYSOSTrial
:DIONYSOSTrial rdf:type owl:NamedIndividual ,
                        obo:OAE_0001197 ,
                        OpenPVSignal:Clinical_trial_information ;
               OpenPVSignal:refers_to_adverse_effect :visionBlurred ;
               OpenPVSignal:refers_to_drug :amiodarone ,
                                           :dronedarone ;
               mp:references :Ref.4 ;
               OpenPVSignal:has_content "There is, however, an isolated report of blurred vision in the DIONYSOS trial which compared the efficacy and safety of amiodarone and dronedarone in patients with persistent AF. In this trial, there was a report of blur- red vision in one of 249 patients taking dronedarone as well as a report of blurred vision in one of 255 patients taking amiodarone.4" ;
               rdfs:label "DIONYSOS trial" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#DiscussionAndConclusion
:DiscussionAndConclusion rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Conclusion ,
                                  OpenPVSignal:Discussion ;
                         mp:references :Ref.1 ,
                                       :Ref.5 ;
                         OpenPVSignal:has_content """Case reports in VigiBase® suggest that there is a signal for the association of dronedarone and vision abnormal. Dronedarone was the only suspected drug in 23 of the 35 reports of vision abnormal. There were other suspected drugs in 11 cases. Amiodarone was another suspected drug in five cases, dabigatran was suspected in two cases, oestrogen and metoprolol suspected in one case each, both silodosil and warfarin in another case, and sotalol, digoxin and bisoprolol in the remaining case. The final case involved a suspected interaction between dronedarone and phenprocoumon. Amiodarone is a well known cause of visual disturbance and is a probable cause in the five cases where it is a suspected drug.3 Digoxin is also a well known cause of chromatopsia and blurred vision.5 The use of dabigatran with dronedarone is contraindicated and there may have been an interaction in these two cases.1
Time to onset is reasonably suggestive of a signal. In the seven reports in which time to onset was reported, it ranged from the same day the drug was started (in three cases) to about seven months. Dechallenge is also suggestive of a signal. The outcome was stated in 19 reports. The patients were reported as recovered or recovering in 15 cases and not recovered in the other four cases. In the cases in which the patient was reported as recovered, the drug was reported to have been withdrawn in 12 cases and continued in the other three cases. In the four cases in which the patient was reported as not recovered, the drug was withdrawn in one case, continued in two cases and the fate of the drug was unknown in the remaining case.
There are a number of reports in which other vision disorders may have been a cause of abnormal vision. These include two reports of eye deposits in which amiodarone is a likely cause, one report of photophobia and one report of retinal vein thrombosis in which amiodarone was also suspected. Two other cases had blindness as well as other visual problems, glaucoma was also reported in two cases and a further two reports described chromatopsia with digoxin as a likely cause in one case and a number of other vision disorders as a likely cause in the other case.
Another report described a vitreous haemorrhage which is a likely cause of abnormal vision and a further report describes oscillopsia which is also a form of abnormal vision.
Leaving aside all the cases in which amiodarone or another vision disorder may have been responsible for abnormal vision (the 13 shaded cases in Table 1), there are 22 remaining cases. Of these, the outcome was stated in 13 cases. Recovery was documented in 11 cases for which the drug was withdrawn in nine of these. The patients in the other two cases had not recovered but the drug was continued. This number of dechallenges in cases which have no other obvious cause supports the possibility of a signal.""" ;
                         rdfs:label "Discussion and conclusion" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Dr_Ian_Boyd
:Dr_Ian_Boyd rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Author ;
             OpenPVSignal:has_first_name "Ian" ;
             OpenPVSignal:has_last_name "Boyd" ;
             rdfs:label "Dr Ian Boyd" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Dronedarone_and_vision_abnormal
:Dronedarone_and_vision_abnormal rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Pharmacovigilance_Signal_Report ;
                                 OpenPVSignal:refers_to_author :Dr_Ian_Boyd ;
                                 OpenPVSignal:refers_to_signal :pvSignal ;
                                 OpenPVSignal:has_creation_date "01/12/2014" ;
                                 OpenPVSignal:has_overall_conclusion "causal association most probable" ;
                                 rdfs:label "Dronedarone and vision abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#EEGAbnormal
:EEGAbnormal rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "R94.01" ;
             OpenPVSignal:has_MedDRA_code 10014408 ;
             OpenPVSignal:has_MedDRA_prefered_term "Electroencephalogram abnormal" ;
             rdfs:label "EEG abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#GIHaemorrhage
:GIHaemorrhage rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "K92.2" ;
               OpenPVSignal:has_MedDRA_code 10017955 ;
               OpenPVSignal:has_MedDRA_prefered_term "Gastrointestinal haemorrhage" ;
               rdfs:label "GI haemorrhage" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#IC025ValueOfDronedaroneAndVisualImpaired
:IC025ValueOfDronedaroneAndVisualImpaired rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component__025_(IC025)> ;
                                          OpenPVSignal:refers_to_adverse_effect :visionAbnormal ;
                                          OpenPVSignal:refers_to_drug :dronedarone ;
                                          OpenPVSignal:refers_to_information_component :ICValueOfDronedaroneAndVisualImpaired ;
                                          OpenPVSignal:has_value -0.77 ;
                                          OpenPVSignal:refers_to_number_of_reports 35 ;
                                          rdfs:label "IC025 value of dronedarone and visual impaired" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#ICValueOfDronedaroneAndVisualImpaired
:ICValueOfDronedaroneAndVisualImpaired rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component_(IC)> ;
                                       OpenPVSignal:refers_to_adverse_effect :visionAbnormal ;
                                       OpenPVSignal:refers_to_drug :dronedarone ;
                                       OpenPVSignal:has_value -0.27 ;
                                       OpenPVSignal:refers_to_number_of_reports 35 ;
                                       rdfs:label "IC value of dronedarone and visual impaired" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#LiteratureAndLabelling
:LiteratureAndLabelling rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Literature_information ;
                        mp:references :Ref.4 ;
                        OpenPVSignal:has_content "The product literature does not refer to vision abnormal. There are no reports of vision abnormal in association with dronedarone in the literature. There is, however, an isolated report of blurred vision in the DIONYSOS trial which compared the efficacy and safety of amiodarone and dronedarone in patients with persistent AF. In this trial, there was a report of blur- red vision in one of 249 patients taking dronedarone as well as a report of blurred vision in one of 255 patients taking amiodarone.4" ;
                        rdfs:label "Literature and labelling" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#MechanismContent
:MechanismContent rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Mechanism ;
                  mp:references :Ref.1 ;
                  OpenPVSignal:has_content "Dronedarone has been shown to prevent atrial fibrillation (AF) or restore normal sinus rhythm depending on the model used. The drug can also prevent ventricular tachycardia and ventricular fibrillation in several animal models. These effects most likely result from its electrophysiological properties belonging to all four Vaughan-Williams classes. Dronedarone is a multichannel blocker inhibiting the potassium currents and thus prolonging cardiac action potential and refractory periods. It also inhibits the sodium currents and the calcium currents. It also non-competitively antagonises adrenergic activities. It is indicated for the maintenance of sinus rhythm after successful cardioversion in adult clinically stable patients with paroxysmal or persistent atrial fibrillation." ;
                  rdfs:label "Mechanism of dronedarone" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#OverallReportsInVigibaseForDronedaroneAndVisionAbnormal
:OverallReportsInVigibaseForDronedaroneAndVisionAbnormal rdf:type owl:NamedIndividual ,
                                                                  OpenPVSignal:Reports_group ;
                                                         OpenPVSignal:refers_to_adverse_effect :visionAbnormal ;
                                                         OpenPVSignal:refers_to_drug :dronedarone ;
                                                         OpenPVSignal:has_count 35 ;
                                                         OpenPVSignal:has_count_of_men 16 ;
                                                         OpenPVSignal:has_count_of_women 19 ;
                                                         OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                         rdfs:label "Overall reports in Vigibase for dronedarone and vision abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient1
:Patient1 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 71 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 1" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient10
:Patient10 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 82 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 10" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient11
:Patient11 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 77 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 11" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient12
:Patient12 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 12" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient13
:Patient13 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 75 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 13" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient14
:Patient14 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 68 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 14" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient15
:Patient15 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 82 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 15" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient16
:Patient16 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 16" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient17
:Patient17 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 70 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 17" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient18
:Patient18 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 65 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 18" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient19
:Patient19 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 70 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 19" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient2
:Patient2 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 74 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 2" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient20
:Patient20 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 79 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 20" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient21
:Patient21 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 80 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 21" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient22
:Patient22 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 70 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 22" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient23
:Patient23 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 68 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 23" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient24
:Patient24 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 61 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 24" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient25
:Patient25 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 68 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 25" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient26
:Patient26 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 60 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 26" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient27
:Patient27 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 78 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 27" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient28
:Patient28 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 70 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 28" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient29
:Patient29 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 29" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient3
:Patient3 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 3" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient30
:Patient30 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 58 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 30" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient31
:Patient31 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 75 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 31" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient32
:Patient32 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 79 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 32" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient33
:Patient33 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 76 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 33" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient34
:Patient34 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 73 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 34" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient35
:Patient35 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 51 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 35" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient4
:Patient4 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 83 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 4" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient5
:Patient5 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 68 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 5" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient6
:Patient6 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 51 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 6" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient7
:Patient7 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 64 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 7" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient8
:Patient8 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 8" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Patient9
:Patient9 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 58 ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 9" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Ref.1
:Ref.1 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "EU SPC for dronedarone (Multaq). URL: http://www. ema.europa.eu/ Accessed: 28 January 2014." ;
       rdfs:label "Ref.1" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Ref.2
:Ref.2 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Council for International Organisations of Medical Sciences (CIOMS). Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for their Use. CIOMS, Geneva, 1999. URL: http://www.cioms.ch/publications/reporting_adver se_drug.pdf/. Accessed: 28 January 2014." ;
       rdfs:label "Ref.2" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Ref.3
:Ref.3 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Therapeutic Goods Administration (TGA) SPC for amiodarone (Cordarone). URL: https://www. ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf? OpenAgent&id=CP-2010-PI-05573-3/. Accessed: 14 February 2014." ;
       rdfs:label "Ref.3" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Ref.4
:Ref.4 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Le Heuzey J-Y, de Ferrari GM, Radzik D, Santini M, Zhu J, Davy J-M. A short-term, randomized, double- blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: The DIONYSOS Study. J Cardiovasc Electrophysiol 2010;51:597-605." ;
       rdfs:label "Ref.4" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#Ref.5
:Ref.5 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Therapeutic Goods Administration (TGA) SPC for digoxin (Lanoxin). URL: https://www.ebs.tga. gov.au. Accessed: 18 February 2014." ;
       rdfs:label "Ref.5" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#ReportsFromCanada
:ReportsFromCanada rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Reports_group ;
                   OpenPVSignal:is_subgroup_of :OverallReportsInVigibaseForDronedaroneAndVisionAbnormal ;
                   OpenPVSignal:has_count 1 ;
                   OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Canada" ;
                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                   rdfs:label "Reports from Canada" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#ReportsFromGermany
:ReportsFromGermany rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Reports_group ;
                    OpenPVSignal:is_subgroup_of :OverallReportsInVigibaseForDronedaroneAndVisionAbnormal ;
                    OpenPVSignal:has_count 7 ;
                    OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Germany" ;
                    OpenPVSignal:refers_to_database "WHO Vigibase" ;
                    rdfs:label "Reports from Germany" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#ReportsFromItaly
:ReportsFromItaly rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Reports_group ;
                  OpenPVSignal:is_subgroup_of :OverallReportsInVigibaseForDronedaroneAndVisionAbnormal ;
                  OpenPVSignal:has_count 1 ;
                  OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Italy" ;
                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                  rdfs:label "Reports from Italy" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#ReportsFromSweden
:ReportsFromSweden rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Reports_group ;
                   OpenPVSignal:is_subgroup_of :OverallReportsInVigibaseForDronedaroneAndVisionAbnormal ;
                   OpenPVSignal:has_count 2 ;
                   OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Sweden" ;
                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                   rdfs:label "Reports from Sweden" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#ReportsFromUnitedKingdom
:ReportsFromUnitedKingdom rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Reports_group ;
                          OpenPVSignal:is_subgroup_of :OverallReportsInVigibaseForDronedaroneAndVisionAbnormal ;
                          OpenPVSignal:has_count 2 ;
                          OpenPVSignal:refers_to_country "http://dbpedia.org/resource/United_Kingdom" ;
                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                          rdfs:label "Reports from United Kingdom" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#ReportsFromUnitedStates
:ReportsFromUnitedStates rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Reports_group ;
                         OpenPVSignal:is_subgroup_of :OverallReportsInVigibaseForDronedaroneAndVisionAbnormal ;
                         OpenPVSignal:has_count 22 ;
                         OpenPVSignal:refers_to_country "http://dbpedia.org/resource/United_States" ;
                         OpenPVSignal:refers_to_database "WHO Vigibase" ;
                         rdfs:label "Reports from United States" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#ReportsInVigibase
:ReportsInVigibase rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Free_text_reporting_element ;
                   mp:references :Ref.3 ;
                   OpenPVSignal:has_content """After the elimination of duplicates, as of January 2014 there are 35 ICSRs of vision abnormal in association with dronedarone in the WHO Global ICSR Database, VigiBase® (Table 1). The association has an IC value of -0.27 with an IC025 value of -0.77. The ICSRs were submitted from the United States (22 cases), Germany (seven cases), United Kingdom, Sweden (two each) and Canada and Italy (one each). The patients ranged in age from 51 to 83 years with a median of 70 years in the 30 cases which provided this information. The gender distribution was 16 males and 19 females. Case 1 is a combination of three reports (triplicate), Case 2 is a combination of two reports (duplicate) and Case 4 is another combination of three reports (triplicate) reports.
Dronedarone was the only suspected drug in 23 of the reports. There were other suspected drugs in eleven cases. Amiodarone was another suspected drug in five cases, dabigatran was suspected in two cases, estrogen and metoprolol suspected in one case each, both silodosin and warfarin in another case, and sotalol, digoxin and bisoprolol in the remaining case. Amiodarone is a well known cause of visual disturbance and is a probable cause in the five cases where it is a suspected drug.3 The final case involved a suspected interaction between dronedarone and phenprocoumon.
Concomitant drugs were reported in the majority of these cases. These indicated a patient population with considerable morbidity and included use of antihypertensives, anticoagulants, hypocholesterolaemic drugs, acetylsalicylic acid, antidiabetic drugs, diuretics and thyroxine.
Dronedarone was reported to have been administered orally, as expected, in the cases which provided this information.
Time to onset was reported in seven of the reports. It ranged from the same day the drug was started (in three cases) to about seven months.
The outcome was stated in 19 reports. The patients were reported as recovered or recovering in 15 cases and not recovered in the other four cases. In the cases in which the patient was reported as recovered, the drug was reported to have been withdrawn in 12 cases and continued in the other three cases. In the four cases in which the patient was reported as not recovered, the drug was withdrawn in one case, continued in two cases and the fate of the drug was unknown in the remaining case.
Other reactions were described in the reports. Neurological reactions include headache, hypoaesthesia, agitation, dizziness and nervousness; cardiovascular reactions, particularly AF; gastrointestinal reactions such as diarrhoea and nausea; respiratory reactions particularly dyspnoea; musculoskeletal reactions and skin reactions. There were also cases where other vision disorders were present including blindness and eye deposits.""" ;
                   rdfs:label "Reports in Vigibase" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#ReportsWithDronedaroneAsTheOnlySuspect
:ReportsWithDronedaroneAsTheOnlySuspect rdf:type owl:NamedIndividual ,
                                                 OpenPVSignal:Reports_group ;
                                        OpenPVSignal:is_subgroup_of :OverallReportsInVigibaseForDronedaroneAndVisionAbnormal ;
                                        OpenPVSignal:refers_to_drug :dronedarone ;
                                        OpenPVSignal:has_count 23 ;
                                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                        rdfs:label "Reports with dronedarone as the only suspect" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#SummaryContent
:SummaryContent rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Summary ;
                OpenPVSignal:has_content "Dronedarone has been shown to prevent atrial fibrillation or restore normal sinus rhythm depending on the model used. It is indicated for the maintenance of sinus rhythm after successful cardioversion in adult clinically stable patients with paroxysmal or persistent atrial fibrillation. In the WHO Global ICSR Database, VigiBase®, there are as of January 2014, 35 reports of vision abnormal in association with dronedarone. The association has an IC value (IC025 value) of -0.27 (-0.77). The ICSRs are submitted from the United States, Germany, United Kingdom, Sweden, Canada and Italy. Although there are some reports in which other vision disorders and/or the use of amiodarone may have been a cause of abnormal vision, the observation of recovery after dechallenge together with a few reports of reasonable time to onset is supportive of a signal." ;
                rdfs:label "Summary content" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#UsageOfDronedarone
:UsageOfDronedarone rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Drug_Usage ;
                    OpenPVSignal:concerns_indication_for_use :atrialFibrillation ;
                    OpenPVSignal:refers_to_drug :dronedarone ;
                    OpenPVSignal:has_content "It is indicated for the maintenance of sinus rhythm after successful cardioversion in adult clinically stable patients with paroxysmal or persistent atrial fibrillation. " ;
                    rdfs:label "Usage of dronedarone" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport1
:VigibaseReport1 rdf:type owl:NamedIndividual ,
                          OpenPVSignal:VigiBase_Report ;
                 OpenPVSignal:refers_to_adverse_effect :abdominalPain ,
                                                       :azotaemia ,
                                                       :bradycardia ,
                                                       :chromatopsia ,
                                                       :creatinineClearanceDecreased ,
                                                       :diarrhoea ,
                                                       :dizziness ,
                                                       :drugInteraction ,
                                                       :hyperkalaemia ,
                                                       :hypotension ,
                                                       :oedema ,
                                                       :oliguria ,
                                                       :prothrombinDecreased ,
                                                       :renalFailureAcute ,
                                                       :therapeuticResponseIncreased ,
                                                       :urineAbnormal ,
                                                       :visionAbnormal ;
                 OpenPVSignal:refers_to_concomitant_drug :allopurinol ,
                                                         :atorvastatin ,
                                                         :candesartan ,
                                                         :doxazosin ,
                                                         :finasteride ,
                                                         :metformin ,
                                                         :omega-3-acidEthylEster ,
                                                         :spironolactone ,
                                                         :warfarin ,
                                                         <http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#potassiumbicarbonate/sodiumAlginate> ;
                 OpenPVSignal:refers_to_patient :Patient1 ;
                 OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                 OpenPVSignal:refers_to_secondary_suspect_drug :bisoprolol ,
                                                               :digoxin ,
                                                               :sotalol ;
                 OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                 rdfs:label "Vigibase Report 1" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport10
:VigibaseReport10 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :dizziness ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :diltiazem ,
                                                          :simvastatin ;
                  OpenPVSignal:refers_to_patient :Patient10 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_secondary_suspect_drug :dabigatran ;
                  OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                  rdfs:label "Vigibase Report 10" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport11
:VigibaseReport11 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :atrialFibrillation ,
                                                        :bradycardia ,
                                                        :chestPain ,
                                                        :glaucoma ,
                                                        :headache ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :atenolol ,
                                                          :lisinopril ,
                                                          :nifedipine ,
                                                          :warfarin ;
                  OpenPVSignal:refers_to_patient :Patient11 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                  rdfs:label "Vigibase Report 11" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport12
:VigibaseReport12 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :arthralgia ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :terazosin ;
                  OpenPVSignal:refers_to_patient :Patient12 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_secondary_suspect_drug :dabigatran ;
                  OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
                  rdfs:label "Vigibase Report 12" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport13
:VigibaseReport13 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :atrialFibrillation ,
                                                        :blindness ,
                                                        :conditionAggravated ,
                                                        :constipation ,
                                                        :haloVision ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :atorvastatin ,
                                                          :clopidogrel ,
                                                          :glibenclamide ,
                                                          :insulinGlargine ,
                                                          :lansoprazole ,
                                                          :levothyroxine ,
                                                          :potassium ,
                                                          :valsartan ;
                  OpenPVSignal:refers_to_patient :Patient13 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                  rdfs:label "Vigibase Report 13" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport14
:VigibaseReport14 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :agitation ,
                                                        :atrialFibrillation ,
                                                        :product_label_issue ,
                                                        :sleepDisorder ,
                                                        :thrombosis_retinal_vein ,
                                                        :thyroidDisorder ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_patient :Patient14 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_secondary_suspect_drug :amiodarone ;
                  OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                  rdfs:label "Vigibase Report 14" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport15
:VigibaseReport15 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :fatigue ,
                                                        :flatulence ,
                                                        :pain ,
                                                        :speechDisorder ,
                                                        :thrombosisCoronary ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :carvedilol ,
                                                          :clopidogrel ,
                                                          :esomeprazole ,
                                                          :gabapentin ,
                                                          :insulin ,
                                                          :insulinGlargine ,
                                                          :insulinLispro ,
                                                          :levothyroxine ,
                                                          :lisinopril ,
                                                          :warfarin ;
                  OpenPVSignal:refers_to_patient :Patient15 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                  rdfs:label "Vigibase Report 15" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport16
:VigibaseReport16 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :diarrhoea ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_patient :Patient16 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                  rdfs:label "Vigibase Report 16" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport17
:VigibaseReport17 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :drugInteraction ,
                                                        :prothrombinDecreased ,
                                                        :visionAbnormal ,
                                                        :vitreousHaemorrhage ;
                  OpenPVSignal:refers_to_concomitant_drug :bisoprolol ,
                                                          :ramipril ,
                                                          <http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hydrochlorothiazide/Triamterene> ;
                  OpenPVSignal:refers_to_interacting_drug :dronedarone ,
                                                          :phenprocoumon ;
                  OpenPVSignal:refers_to_patient :Patient17 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "recovering" ;
                  rdfs:label "Vigibase Report 17" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport18
:VigibaseReport18 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :angleClosureGlaucoma ,
                                                        :arrhythmia ,
                                                        :atrialFibrillation ,
                                                        :blepharospasm ,
                                                        :depression ,
                                                        :eyeAbnormality ,
                                                        :eyePain ,
                                                        :hyperglycaemia ,
                                                        :pulmonaryDisorders ,
                                                        :rashErythematous ,
                                                        :sleepDisorder ,
                                                        :tension_headache ,
                                                        :visionAbnormal ,
                                                        :wheezing ;
                  OpenPVSignal:refers_to_concomitant_drug :AcetylsalicylicAcid ,
                                                          :alprazolam ,
                                                          :atorvastatin ,
                                                          :fishOil ,
                                                          :risedronicAcid ,
                                                          :rosuvastatin ,
                                                          :vitaminsWithMinerals ,
                                                          <http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#colecalciferol/calciumCarbonate> ;
                  OpenPVSignal:refers_to_patient :Patient18 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
                  rdfs:label "Vigibase Report 18" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport19
:VigibaseReport19 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :agitation ,
                                                        :atrialFibrillation ,
                                                        :tachycardiaSupraventricular ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :atorvastatin ,
                                                          :bisoprolol ;
                  OpenPVSignal:refers_to_patient :Patient19 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                  rdfs:label "Vigibase Report 19" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport2
:VigibaseReport2 rdf:type owl:NamedIndividual ,
                          OpenPVSignal:VigiBase_Report ;
                 OpenPVSignal:refers_to_adverse_effect :EEGAbnormal ,
                                                       :blindness ,
                                                       :blindness_colour ,
                                                       :chromatopsia ,
                                                       :eyePain ,
                                                       :headache ,
                                                       :opticAtrophy ,
                                                       :opticNeuritis ,
                                                       :papilloedema ,
                                                       :photopsia ,
                                                       :pupillaryReflexImpaired ,
                                                       :scotoma ,
                                                       :visionAbnormal ,
                                                       :visualFieldDefect ,
                                                       :vitreousFloaters ;
                 OpenPVSignal:refers_to_patient :Patient2 ;
                 OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                 OpenPVSignal:refers_to_outcome_after_action "recovering" ;
                 rdfs:label "Vigibase Report 2" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport20
:VigibaseReport20 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :abdominalPain ,
                                                        :dyspepsia ,
                                                        :headache ,
                                                        :skeletalPain ,
                                                        :urinaryIncontinence ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :adalimumab ,
                                                          :metoprolol ,
                                                          :verapamil ,
                                                          :warfarin ;
                  OpenPVSignal:refers_to_patient :Patient20 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                  rdfs:label "Vigibase Report 20" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport21
:VigibaseReport21 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :abdominalPain ,
                                                        :tinnitus ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_patient :Patient21 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                  rdfs:label "Vigibase Report 21" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport22
:VigibaseReport22 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :drugLevelDecreased ,
                                                        :prothrombinDecreased ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :atenolol ,
                                                          :diltiazem ,
                                                          :levothyroxine ,
                                                          :warfarin ;
                  OpenPVSignal:refers_to_patient :Patient22 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "recovering" ;
                  rdfs:label "Vigibase Report 22" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport23
:VigibaseReport23 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :anxiety ,
                                                        :dizziness ,
                                                        :dyspnoea ,
                                                        :gaitAbnormal ,
                                                        :hallucination ,
                                                        :medicationError ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :AcetylsalicylicAcid ,
                                                          :atorvastatin ,
                                                          :heparin ,
                                                          :nebivolol ,
                                                          :pantoprazole ,
                                                          :valsartan ,
                                                          :zinc ;
                  OpenPVSignal:refers_to_patient :Patient23 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                  rdfs:label "Vigibase Report 23" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport24
:VigibaseReport24 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :agitation ,
                                                        :atrialFibrillation ,
                                                        :diarrhoea ,
                                                        :nausea ,
                                                        :nervousness ,
                                                        :oedema ,
                                                        :skinDisorder ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_patient :Patient24 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
                  rdfs:label "Vigibase Report 24" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport25
:VigibaseReport25 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :atrialFibrillation ,
                                                        :confusion ,
                                                        :neuropathyPeripheral ,
                                                        :oedemaPeripheral ,
                                                        :visionAbnormal ,
                                                        :weightDecrease ;
                  OpenPVSignal:refers_to_concomitant_drug :digoxin ,
                                                          :glipizide ,
                                                          :lisinopril ,
                                                          :metoprolol ,
                                                          :nicotinic_acid ,
                                                          :simvastatin ,
                                                          :vitamin_B_complex ,
                                                          :warfarin ;
                  OpenPVSignal:refers_to_patient :Patient25 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                  rdfs:label "Vigibase Report 25" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport26
:VigibaseReport26 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :cardiacFailure ,
                                                        :depersonalization ,
                                                        :dizziness ,
                                                        :dyspnoea ,
                                                        :dysuria ,
                                                        :hypertension ,
                                                        :nausea ,
                                                        :oedemaPeripheral ,
                                                        :renalFailureChronic ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :AcetylsalicylicAcid ,
                                                          :enalapril ,
                                                          :pravastatin ,
                                                          :warfarin ;
                  OpenPVSignal:refers_to_patient :Patient26 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_secondary_suspect_drug :metoprolol ;
                  OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                  rdfs:label "Vigibase Report 26" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport27
:VigibaseReport27 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :drugInteraction ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_patient :Patient27 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_secondary_suspect_drug :silodosin ,
                                                                :warfarin ;
                  OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                  rdfs:label "Vigibase Report 27" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport28
:VigibaseReport28 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :abdomenEnlarged ,
                                                        :atrialFibrillation ,
                                                        :blindness ,
                                                        :cerebrovascularDisorder ,
                                                        :dyspnoea ,
                                                        :fatigue ,
                                                        :hemianopiaHomonymous ,
                                                        :myalgia ,
                                                        :nausea ,
                                                        :ocularHaemorrhage ,
                                                        :qualityOfLifeDecreased ,
                                                        :sleepDisorder ,
                                                        :visionAbnormal ,
                                                        :weightIncrease ;
                  OpenPVSignal:refers_to_patient :Patient28 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                  rdfs:label "Vigibase Report 28" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport29
:VigibaseReport29 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :GIHaemorrhage ,
                                                        :arrhythmia ,
                                                        :atrialFibrillation ,
                                                        :bloodCountAbnormal ,
                                                        :confusion ,
                                                        :coughing ,
                                                        :depression ,
                                                        :dyspnoea ,
                                                        :emotionalLability ,
                                                        :fatigue ,
                                                        :headache ,
                                                        :hypoaesthesia ,
                                                        :muscleWeakness ,
                                                        :myalgia ,
                                                        :nervousness ,
                                                        :paraesthesia ,
                                                        :photosensitivityReaction ,
                                                        :pleuralEffusion ,
                                                        :product_quality_issue ,
                                                        :rigors ,
                                                        :sleepDisorder ,
                                                        :tremor ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_patient :Patient29 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_secondary_suspect_drug :amiodarone ;
                  OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                  rdfs:label "Vigibase Report 29" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport3
:VigibaseReport3 rdf:type owl:NamedIndividual ,
                          OpenPVSignal:VigiBase_Report ;
                 OpenPVSignal:refers_to_adverse_effect :ataxia ,
                                                       :atrialFibrillation ,
                                                       :colonCarcinoma ,
                                                       :conditionAggravated ,
                                                       :confusion ,
                                                       :gaitAbnormal ,
                                                       :hypoaesthesia ,
                                                       :hypotension ,
                                                       :muscleWeakness ,
                                                       :nervousness ,
                                                       :painInExtremity ,
                                                       :photophobia ,
                                                       :pneumonia ,
                                                       :purpura ,
                                                       :rash ,
                                                       :skinDiscolouration ,
                                                       :tremor ,
                                                       :visionAbnormal ;
                 OpenPVSignal:refers_to_concomitant_drug :amlodipine ,
                                                         :carvedilol ,
                                                         :fishOil ,
                                                         :furosemide ,
                                                         :hydralazine ,
                                                         :ubidecarenone ,
                                                         :warfarin ;
                 OpenPVSignal:refers_to_patient :Patient3 ;
                 OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                 OpenPVSignal:refers_to_secondary_suspect_drug :amiodarone ;
                 OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
                 rdfs:label "Vigibase Report 3" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport30
:VigibaseReport30 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :abdominalPain ,
                                                        :depression ,
                                                        :headache ,
                                                        :lacrimationAbnormal ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :hydrochlorothiazide ,
                                                          :paracetamol ,
                                                          :warfarin ;
                  OpenPVSignal:refers_to_patient :Patient30 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                  rdfs:label "Vigibase Report 30" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport31
:VigibaseReport31 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :oscillopsia ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :metoprolol ,
                                                          :phenprocoumon ,
                                                          :pravastatin ,
                                                          :ramipril ;
                  OpenPVSignal:refers_to_patient :Patient31 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                  rdfs:label "Vigibase Report 31" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport32
:VigibaseReport32 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :hallucination ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :AcetylsalicylicAcid ,
                                                          :amlodipine ,
                                                          :clonidine ,
                                                          :glipizide ,
                                                          :glycerylTrinitrate ,
                                                          :insulin ,
                                                          :isosorbideDinitrate ,
                                                          :labetalol ,
                                                          :lansoprazole ,
                                                          :methyldopa ,
                                                          <http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#phenobarbital/atropine_sulfate/hyoscine_hydrobromide/hyoscyamine_sulphate> ;
                  OpenPVSignal:refers_to_patient :Patient32 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                  rdfs:label "Vigibase Report 32" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport33
:VigibaseReport33 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :blindness_temporary ,
                                                        :cornealDeposits ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :clopidogrel ,
                                                          :lovastatin ,
                                                          :nicotinic_acid ,
                                                          <http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#benazeprilhydrochloride/amlodipine> ;
                  OpenPVSignal:refers_to_patient :Patient33 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_secondary_suspect_drug :amiodarone ;
                  OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                  rdfs:label "Vigibase Report 33" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport34
:VigibaseReport34 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :cardiacFailure ,
                                                        :dyspnoea ,
                                                        :oedema ,
                                                        :visionAbnormal ,
                                                        :weightIncrease ;
                  OpenPVSignal:refers_to_concomitant_drug :digoxin ,
                                                          :fishOil ,
                                                          :glycerylTrinitrate ,
                                                          :metformin ,
                                                          :metoprolol ,
                                                          :rosuvastatin ,
                                                          :tadalafil ,
                                                          :testosterone ,
                                                          :vitamins ,
                                                          :warfarin ,
                                                          <http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hydrochlorothiazide/lisinopril> ;
                  OpenPVSignal:refers_to_patient :Patient34 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                  rdfs:label "Vigibase Report 34" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport35
:VigibaseReport35 rdf:type owl:NamedIndividual ,
                           OpenPVSignal:VigiBase_Report ;
                  OpenPVSignal:refers_to_adverse_effect :arrhythmia ,
                                                        :leg_pain ,
                                                        :myalgia ,
                                                        :visionAbnormal ;
                  OpenPVSignal:refers_to_concomitant_drug :AcetylsalicylicAcid ,
                                                          :b_blockers ,
                                                          :simvastatin ;
                  OpenPVSignal:refers_to_patient :Patient35 ;
                  OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                  OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                  rdfs:label "Vigibase Report 35" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport4
:VigibaseReport4 rdf:type owl:NamedIndividual ,
                          OpenPVSignal:VigiBase_Report ;
                 OpenPVSignal:refers_to_adverse_effect :deposit_eye ,
                                                       :photosensitivityReaction ,
                                                       :rashPsoriaform ,
                                                       :skinExfoliation ,
                                                       :visionAbnormal ;
                 OpenPVSignal:refers_to_patient :Patient4 ;
                 OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                 OpenPVSignal:refers_to_secondary_suspect_drug :amiodarone ;
                 OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                 rdfs:label "Vigibase Report 4" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport5
:VigibaseReport5 rdf:type owl:NamedIndividual ,
                          OpenPVSignal:VigiBase_Report ;
                 OpenPVSignal:refers_to_adverse_effect :hearingDecreased ,
                                                       :visionAbnormal ;
                 OpenPVSignal:refers_to_concomitant_drug :levothyroxine ,
                                                         :rivaroxaban ;
                 OpenPVSignal:refers_to_patient :Patient5 ;
                 OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                 OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                 rdfs:label "Vigibase Report 5" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport6
:VigibaseReport6 rdf:type owl:NamedIndividual ,
                          OpenPVSignal:VigiBase_Report ;
                 OpenPVSignal:refers_to_adverse_effect :alcoholProblem ,
                                                       :comaHepatic ,
                                                       :diarrhoea ,
                                                       :fatigue ,
                                                       :headache ,
                                                       :hyperammonaemia ,
                                                       :hypoaesthesia ,
                                                       :liverFatty ,
                                                       :rigors ,
                                                       :sweatingIncreased ,
                                                       :urinaryIncontinence ,
                                                       :visionAbnormal ,
                                                       :weightDecrease ;
                 OpenPVSignal:refers_to_patient :Patient6 ;
                 OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                 OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                 rdfs:label "Vigibase Report 6" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport7
:VigibaseReport7 rdf:type owl:NamedIndividual ,
                          OpenPVSignal:VigiBase_Report ;
                 OpenPVSignal:refers_to_adverse_effect :headache ,
                                                       :hepaticEnzymesIncreased ,
                                                       :visionAbnormal ;
                 OpenPVSignal:refers_to_patient :Patient7 ;
                 OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                 OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                 rdfs:label "Vigibase Report 7" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport8
:VigibaseReport8 rdf:type owl:NamedIndividual ,
                          OpenPVSignal:VigiBase_Report ;
                 OpenPVSignal:refers_to_adverse_effect :hypoaesthesia ,
                                                       :polyneuropathy ,
                                                       :visionAbnormal ;
                 OpenPVSignal:refers_to_concomitant_drug :lercanidipine ,
                                                         :metoprolol ,
                                                         :phenprocoumon ,
                                                         :pravastatin ;
                 OpenPVSignal:refers_to_patient :Patient8 ;
                 OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                 OpenPVSignal:refers_to_outcome_after_action "recovery with sequelae" ;
                 rdfs:label "Vigibase Report 8" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#VigibaseReport9
:VigibaseReport9 rdf:type owl:NamedIndividual ,
                          OpenPVSignal:VigiBase_Report ;
                 OpenPVSignal:refers_to_adverse_effect :allergicReaction ,
                                                       :chestPain ,
                                                       :diarrhoea ,
                                                       :dyspnoea ,
                                                       :insomnia ,
                                                       :oedemaPeripheral ,
                                                       :rash ,
                                                       :thrombosis ,
                                                       :visionAbnormal ,
                                                       :weightIncrease ;
                 OpenPVSignal:refers_to_concomitant_drug :AcetylsalicylicAcid ,
                                                         :salbutamol ;
                 OpenPVSignal:refers_to_patient :Patient9 ;
                 OpenPVSignal:refers_to_primary_suspect_drug :dronedarone ;
                 OpenPVSignal:refers_to_secondary_suspect_drug :estrogen ;
                 OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                 rdfs:label "Vigibase Report 9" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#abdomenEnlarged
:abdomenEnlarged rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "R140" ;
                 OpenPVSignal:has_MedDRA_code 10000045 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Abdomen enlarged" ;
                 rdfs:label "abdomen enlarged" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#abdominalPain
:abdominalPain rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "R109" ;
               OpenPVSignal:has_MedDRA_code 10000081 ;
               OpenPVSignal:has_MedDRA_prefered_term "Abdominal pain" ;
               rdfs:label "abdominal pain" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#adalimumab
:adalimumab rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "L04AB04" ;
            rdfs:label "adalimumab" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#agitation
:agitation rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "R451" ;
           OpenPVSignal:has_MedDRA_code 10001497 ;
           OpenPVSignal:has_MedDRA_prefered_term "Agitation" ;
           rdfs:label "agitation" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#alcoholProblem
:alcoholProblem rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "F10.20" ;
                OpenPVSignal:has_MedDRA_code 10001606 ;
                OpenPVSignal:has_MedDRA_prefered_term "Alcohol problem" ;
                rdfs:label "alcohol problem" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#allergicReaction
:allergicReaction rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "T7840XA" ;
                  OpenPVSignal:has_MedDRA_code 10001718 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Allergic reaction" ;
                  rdfs:label "allergic reaction" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#allopurinol
:allopurinol rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "M04AA01" ,
                                       "M04AA51" ;
             rdfs:label "allopurinol" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#alprazolam
:alprazolam rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N05BA12" ;
            rdfs:label "alprazolam" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#amblyopia
:amblyopia rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "H53.049" ;
           OpenPVSignal:has_MedDRA_code 10001906 ;
           OpenPVSignal:has_MedDRA_prefered_term "Amblyopia" ;
           rdfs:label "amblyopia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#amiodarone
:amiodarone rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C01BD01" ;
            rdfs:label "amiodarone" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#amiodarone_as_known_cause_of_visual_disturbance
:amiodarone_as_known_cause_of_visual_disturbance rdf:type owl:NamedIndividual ,
                                                          obo:OAE_0001182 ;
                                                 OpenPVSignal:refers_to_adverse_effect :visualDisturbance ;
                                                 OpenPVSignal:refers_to_drug :amiodarone ;
                                                 mp:references :Ref.3 ;
                                                 OpenPVSignal:has_content "Amiodarone is a well known cause of visual disturbance and is a probable cause in the five cases where it is a suspected drug.3" ;
                                                 rdfs:label "amiodarone as known cause of visual disturbance" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#amlodipine
:amlodipine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C08CA01" ,
                                      "C08GA02" ,
                                      "C09BB03" ,
                                      "C09BB04" ,
                                      "C09BB07" ,
                                      "C09BX01" ,
                                      "C09DB01" ,
                                      "C09DB02" ,
                                      "C09DB04" ,
                                      "C09DB05" ,
                                      "C09DB06" ,
                                      "C09DB07" ,
                                      "C09DX01" ,
                                      "C09DX03" ,
                                      "C09XA53" ,
                                      "C09XA54" ,
                                      "C10BX03" ,
                                      "C10BX07" ,
                                      "C10BX09" ,
                                      "C10BX11" ;
            rdfs:label "amlodipine" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#angleClosureGlaucoma
:angleClosureGlaucoma rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Adverse_Effect ;
                      OpenPVSignal:has_ICD_code "H40.2" ;
                      OpenPVSignal:has_MedDRA_code 10002500 ;
                      OpenPVSignal:has_MedDRA_prefered_term "angle closure glaucoma" ;
                      rdfs:label "angle closure glaucoma" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#answer_from
:answer_from rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Response_to_Pharmacovigilance_Signal_Report ;
             OpenPVSignal:refers_to_signal :pvSignal ;
             OpenPVSignal:has_content """Response from Sanofi
Dronedarone is similar to amiodarone in its molecular structure with an important difference consisting in the presence of methylsulfonamide group to reduce solubility in fats (lipophilicity) and thus reduce neurotoxic effects. As dronedarone might theoretically share the latter class effect, close surveillance of neuropathy ADRs including optic neuropathy has been performed since launch by the MAH via routine pharmacovigilance, namely in subsequent 6-month PSURs and as a potential pharmacological class effect in the Risk Management Plan updates. Periodic analyses of the cases did not confirm an evidence of a causal link between dronedarone and neurologic disorders including neuropathy not otherwise specified (NOS) or optic neuropathy (using MedDRA standardized query “Optic nerve disorders_Broad+Narrow”). This conclusion was endorsed by EMA in the Assessment Report to the most recently submitted PSUR7 (September 2013).
From launch of dronedarone to 31 January 2014, a total of 115 cases (3 solicited and 112 unsolicited:
62 medically confirmed and 50 consumer; 70 serious and 45 nonserious) pertaining to the HLGT “vision disorders” were collected worldwide. They referred to 137 reactions mainly coded with the following MedDRA preferred terms: visual impairment (n=49), vision blurred (n=46) or visual acuity reduced (n=11), concerned 55 women and 51 men (unspecified in 9 cases), aged between 43 and 90 years (median: 72 years; unspecified in 22 cases). Onset dates were available in 37 out of 65 medically confirmed cases (a few hours-2.3 years).
In 40 out of 115 cases, dronedarone was withdrawn, leading to favorable outcome in 26 cases, but information on corrective treatment, if any, was missing in all but 1 case where furosemide was used as corrective treatment. In one case, rechallenge was performed but was negative.
Among the 65 medically confirmed cases, ophthalmological investigations results were only provided in 1 case.
Concerning the 3 solicited cases, in 2 cases, the insufficient documentation did not allow drawing a clear conclusion, and in 1 case, the patient’s underlying visual disorders NOS provide an alternative explanation.
Concerning the 62 unsolicited medically confirmed cases:
•	In 1 case, dronedarone rechallenge was negative.
•	In 29 cases, the case documentation elements were not sufficient to allow drawing a clear conclusion.
•	In 10 cases, treatment with amiodarone provides a more likely explanation.
•	In 4 cases, treatment with digoxin provides a more likely explanation.
•	In 4 cases, the patient’s underlying condition provides a plausible alternative explanation: medical history of abnormal vision NOS (n=1), multiple risk factors potentially inducing ischemic optic neuropathy, retinal detachment and macular edema (n=1), optic neuritis since amiodarone therapy in a patient with multiple risk factors including among other recent treatment for metastatic breast cancer (n=1), hypertension in a patient experiencing “flickering in the eyes” (n=1).
•	In 4 cases, visual disturbances occurred in a specific context that explains its occurrence: vitrous hemorrhage with increased PT under VKA therapy (n=1), occipitotemporal infarction in a patient with multiple risk factors (TIA, cerebral infarction) (n=1), syncope and dehydration in 1 case of “vision blackout” (coded transient blindness), very recent TIA in a patient with contributive underlying condition and concomitant treatments (n=1).
•	In 1 case, concomitant silodosin provides a more likely explanation.
•	In 1 case, the patient’s medical history was relevant for severe coronary artery disease, vascular disease, diabetes and hypertension, and concomitant treatments included clonazepam, lamotrigine and metoprolol.
•	In 1 case, the patient, with unknown medical history, had normal ophtalmological investigation NOS and concomitant treatment with venlafaxine.
In 1 case of optic nerve atrophy and papilloedema, missing information on neurological and ophthalmological investigation results at baseline did not allow a proper medical assessment. Furthermore, poor blood flow causing ischemic optic neuropathy may dronedarone group, versus 0.2% in the placebo group. Vision blurred was reported in 1 patient in each group (< 0.1%).
Based on available up-to-date information the MAH concludes that there is insufficient evidence
 
to support a causal association between dronedarone and vision abnormal. The MAH will continue to monitor this topic in the next PSUR.
•	
 
have contributed to the development of optic atrophy that may be secondary to prolonged papilloedema.
•	In the following 6 cases, vision disorder were associated with others events:
-	Context of congestive heart failure in a patient with glaucoma and diabetes mellitus, and relevant concomitant digoxin (n=1).
-	Face and lips edema, in a patient with diabetes mellitus (n=1).
-	Hallucinations in a patient with diabetes mellitus, coronary heart disease and hypertension concomitantly treated with phenobarbital, clonidine and methyldopa (n=1).
-	Dizziness and headache in a patient with digoxin therapy, diabetes, hypertension, concomitantly treated with hydrocodone, carvedilol and pantoprazole (n=1).
-	Balance disorder, dizziness and fatigue in a patient with hypothyroidism, and concomitant treatments relevant for nebivolol, omeprazole, and primidone (n=1).
-	Headache in a patient with hypertension and concomitant treatments for hydrochlorothiazide (n=1).
Concerning the 50 consumer cases, ophthalmic investigations results were performed in 4 cases and without findings. Overall, the case documentation elements were not sufficient to allow drawing a clear conclusion. Moreover alternative explanations or confounding factors were reported in most of the cases.
In context of pharmacovigilance activities to assess the risk of optic neuritis, peripheral neuropathy, and muscular disorders in patients treated with dronedarone compared with amiodarone and other antiarrhythmics, an epidemiology study (DRONE C06714) was performed by MAH using the MarketScan database. The results showed no evidence that dronedarone was associated with significantly higher risks of optic neuritis, peripheral neuropathy compared to other antiarrhythmics. Final report was submitted in the previous RMP version 9.
In placebo-controlled clinical trial program in the pooled population, vision disorders were reported in 1.3% of patients in dronedarone and 1.1% of patients in placebo groups. Incidence of vision blurred was 0.6% in both treatment groups.
In the DIONYSOS study, no differences concerning vision disorders were observed. A trend towards less photophobia and blurred vision was observed in the dronedarone compared to the amiodarone group.
In Pallas study, peripheral neuropathies, including optic neuropathy were reported in 0.4% in the dronedarone group, versus 0.2% in the placebo group. Vision blurred was reported in 1 patient in each group (< 0.1%). Based on available up-to-date information the MAH concludes that there is insufficient evidence to support a causal association between dronedarone and vision abnormal. The MAH will continue to monitor this topic in the next PSUR.""" ;
             rdfs:label "response from sanofi" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#anxiety
:anxiety rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "F419" ;
         OpenPVSignal:has_MedDRA_code 10002855 ;
         OpenPVSignal:has_MedDRA_prefered_term "Anxiety" ;
         rdfs:label "anxiety" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#arrhythmia
:arrhythmia rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "I499" ;
            OpenPVSignal:has_MedDRA_code 10003119 ;
            OpenPVSignal:has_MedDRA_prefered_term "Arrhythmia" ;
            rdfs:label "arrhythmia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#arthralgia
:arthralgia rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "M2550" ;
            OpenPVSignal:has_MedDRA_code 10003239 ;
            OpenPVSignal:has_MedDRA_prefered_term "Arthralgia" ;
            rdfs:label "arthralgia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#asthenia
:asthenia rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R53.1" ;
          OpenPVSignal:has_MedDRA_code 10003549 ;
          OpenPVSignal:has_MedDRA_prefered_term "Asthenia" ;
          rdfs:label "asthenia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#asthenopia
:asthenopia rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "H53.149" ;
            OpenPVSignal:has_MedDRA_code 10003552 ;
            OpenPVSignal:has_MedDRA_prefered_term "Asthenopia" ;
            rdfs:label "asthenopia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#ataxia
:ataxia rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "R270" ;
        OpenPVSignal:has_MedDRA_code 10003591 ;
        OpenPVSignal:has_MedDRA_prefered_term "Ataxia" ;
        rdfs:label "ataxia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#atenolol
:atenolol rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "C07AB03" ,
                                    "C07BB03" ,
                                    "C07CB03" ,
                                    "C07CB53" ,
                                    "C07DB01" ,
                                    "C07FB03" ;
          rdfs:label "atenolol" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#atorvastatin
:atorvastatin rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "C10AA05" ,
                                        "C10BA05" ,
                                        "C10BX03" ,
                                        "C10BX06" ,
                                        "C10BX08" ,
                                        "C10BX11" ;
              rdfs:label "atorvastatin" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#atrialFibrillation
:atrialFibrillation rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Indication ;
                    OpenPVSignal:has_MedDRA_code 10003658 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Atrial fibrillation" ;
                    rdfs:label "atrial fibrillation" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#azotaemia
:azotaemia rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "R7989" ;
           OpenPVSignal:has_MedDRA_code 10003885 ;
           OpenPVSignal:has_MedDRA_prefered_term "Azotaemia" ;
           rdfs:label "azotaemia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#b_blockers
:b_blockers rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C07A" ;
            rdfs:label "b blockers" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#bisoprolol
:bisoprolol rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C07AB07" ,
                                      "C07AB57" ,
                                      "C07BB07" ,
                                      "C07FB07" ,
                                      "C09BX02" ;
            rdfs:label "bisoprolol" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#blepharospasm
:blepharospasm rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "M791" ;
               OpenPVSignal:has_MedDRA_code 10005159 ;
               OpenPVSignal:has_MedDRA_prefered_term "Blepharospasm" ;
               rdfs:label "blepharospasm" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#blindness
:blindness rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "H54" ;
           OpenPVSignal:has_MedDRA_code 10005169 ;
           OpenPVSignal:has_MedDRA_prefered_term "Blindness" ;
           rdfs:label "blindness" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#blindness_colour
:blindness_colour rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_MedDRA_code 10005173 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Blindness colour" ;
                  rdfs:label "blindness colour" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#blindness_temporary
:blindness_temporary rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_MedDRA_code 10005183 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Blindness temporary" ;
                     rdfs:label "blindness temporary" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#bloodCountAbnormal
:bloodCountAbnormal rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_MedDRA_code 10064198 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Blood count abnormal" ;
                    rdfs:label "blood count abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#bradycardia
:bradycardia rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "R001" ;
             OpenPVSignal:has_MedDRA_code 10006093 ;
             OpenPVSignal:has_MedDRA_prefered_term "Bradycardia" ;
             rdfs:label "bradycardia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#candesartan
:candesartan rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C09CA06" ,
                                       "C09DA06" ,
                                       "C09DB07" ;
             rdfs:label "candesartan" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#cardiacFailure
:cardiacFailure rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "I50" ;
                OpenPVSignal:has_MedDRA_code 10007554 ;
                OpenPVSignal:has_MedDRA_prefered_term "Cardiac failure" ;
                rdfs:label "cardiac failure" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#carvedilol
:carvedilol rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C07AG02" ;
            rdfs:label "carvedilol" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#cerebrovascularDisorder
:cerebrovascularDisorder rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Adverse_Effect ;
                         OpenPVSignal:has_ICD_code "I679" ;
                         OpenPVSignal:has_MedDRA_code 10008196 ;
                         OpenPVSignal:has_MedDRA_prefered_term "Cerebrovascular disorder" ;
                         rdfs:label "cerebrovascular disorder" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#chestPain
:chestPain rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "R07" ;
           OpenPVSignal:has_MedDRA_code 10008479 ;
           OpenPVSignal:has_MedDRA_prefered_term "Chest pain" ;
           rdfs:label "chest pain" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#chromatopsia
:chromatopsia rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "H53.59" ;
              OpenPVSignal:has_MedDRA_code 10008795 ;
              OpenPVSignal:has_MedDRA_prefered_term "Chromatopsia" ;
              rdfs:label "chromatopsia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#clonidine
:clonidine rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C02AC01" ,
                                     "C02LC01" ,
                                     "C02LC51" ,
                                     "N02CX02" ,
                                     "S01EA04" ;
           rdfs:label "clonidine" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#clopidogrel
:clopidogrel rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "B01AC04" ;
             rdfs:label "clopidogrel" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#colonCarcinoma
:colonCarcinoma rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "C189" ;
                OpenPVSignal:has_MedDRA_code 10009944 ;
                OpenPVSignal:has_MedDRA_prefered_term "Colon cancer" ;
                rdfs:label "colon carcinoma" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#comaHepatic
:comaHepatic rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_MedDRA_code 10010075 ;
             OpenPVSignal:has_MedDRA_prefered_term "coma hepatic" ;
             rdfs:label "hepatic coma" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#conditionAggravated
:conditionAggravated rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_ICD_code " F918" ;
                     OpenPVSignal:has_MedDRA_code 10010264 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Condition aggravated" ;
                     rdfs:label "condition aggravated" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#confusion
:confusion rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "F448" ;
           OpenPVSignal:has_MedDRA_code 10010305 ;
           OpenPVSignal:has_MedDRA_prefered_term "Confusional state" ;
           rdfs:label "confusion" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#congestiveHeartFailure
:congestiveHeartFailure rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_ICD_code "I50.2" ;
                        OpenPVSignal:has_MedDRA_code 10010684 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Congestive heart failure" ;
                        rdfs:label "congestive heart failure" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#constipation
:constipation rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "K590" ;
              OpenPVSignal:has_MedDRA_code 10010774 ;
              OpenPVSignal:has_MedDRA_prefered_term "Constipation" ;
              rdfs:label "constipation" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#cornealDeposits
:cornealDeposits rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_MedDRA_code 10011000 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Corneal deposits" ;
                 rdfs:label "corneal deposits" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#coughing
:coughing rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R05" ;
          OpenPVSignal:has_MedDRA_code 10011224 ;
          OpenPVSignal:has_MedDRA_prefered_term "Cough" ;
          rdfs:label "coughing" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#creatinineClearanceDecreased
:creatinineClearanceDecreased rdf:type owl:NamedIndividual ,
                                       OpenPVSignal:Adverse_Effect ;
                              OpenPVSignal:has_ICD_code "R944" ;
                              OpenPVSignal:has_MedDRA_code 10011372 ;
                              OpenPVSignal:has_MedDRA_prefered_term "Creatinine renal clearance decreased" ;
                              rdfs:label "creatinine clearance decreased" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#dabigatran
:dabigatran rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "B01AE07" ;
            rdfs:label "dabigatran" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#dabigatran_and_dronaderone_interaction
:dabigatran_and_dronaderone_interaction rdf:type owl:NamedIndividual ,
                                                 obo:OAE_0001197 ;
                                        OpenPVSignal:refers_to_interacting_drug :dabigatran ,
                                                                                :dronedarone ;
                                        mp:references :Ref.1 ;
                                        OpenPVSignal:has_content "The use of dabigatran with dronedarone is contraindicated and there may have been an interaction in these two cases.1" ;
                                        rdfs:label "dabigatran and dronaderone interaction" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#depersonalization
:depersonalization rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "F48.1" ;
                   OpenPVSignal:has_MedDRA_code 10012359 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Depersonalization" ;
                   rdfs:label "Depersonalization" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#deposit_eye
:deposit_eye rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_MedDRA_code 10012369 ;
             OpenPVSignal:has_MedDRA_prefered_term "Deposit eye" ;
             rdfs:label "deposit eye" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#depression
:depression rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "F33" ;
            OpenPVSignal:has_MedDRA_code 10012378 ;
            OpenPVSignal:has_MedDRA_prefered_term "Depression" ;
            rdfs:label "depression" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#depthPerceptionDifficulty
:depthPerceptionDifficulty rdf:type owl:NamedIndividual ,
                                    OpenPVSignal:Adverse_Effect ;
                           OpenPVSignal:has_ICD_code "H53.33" ;
                           OpenPVSignal:has_MedDRA_code 10053549 ;
                           OpenPVSignal:has_MedDRA_prefered_term "Altered visual depth perception" ;
                           rdfs:label "depth perception difficulty" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#diarrhoea
:diarrhoea rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "R197" ;
           OpenPVSignal:has_MedDRA_code 10012735 ;
           OpenPVSignal:has_MedDRA_prefered_term "Diarrhoea" ;
           rdfs:label "diarrhoea" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#digoxin
:digoxin rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Drug ;
         OpenPVSignal:has_ATC_code "C01AA05" ;
         rdfs:label "digoxin" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#digoxin_and_vision_abnormal
:digoxin_and_vision_abnormal rdf:type owl:NamedIndividual ,
                                      obo:OAE_0001182 ;
                             OpenPVSignal:refers_to_adverse_effect :chromatopsia ,
                                                                   :visionBlurred ;
                             OpenPVSignal:refers_to_drug :digoxin ;
                             mp:references :Ref.5 ;
                             OpenPVSignal:has_content "Digoxin is also a well known cause of chromatopsia and blurred vision.5" ;
                             rdfs:label "digoxin and vision abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#diltiazem
:diltiazem rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C05AE03" ,
                                     "C08DB01" ;
           rdfs:label "diltiazem" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#dizziness
:dizziness rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "R42" ;
           OpenPVSignal:has_MedDRA_code 10013573 ;
           OpenPVSignal:has_MedDRA_prefered_term "Dizziness" ;
           rdfs:label "dizziness" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#doxazosin
:doxazosin rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C02CA04" ;
           rdfs:label "doxazosin" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#dronedarone
:dronedarone rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_mechanism :MechanismContent ;
             OpenPVSignal:has_ATC_code "C01BD07" ;
             rdfs:label "dronedarone" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#dronedaroneAndCardiacDisorders
:dronedaroneAndCardiacDisorders rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Warning_Information ;
                                OpenPVSignal:refers_to_adverse_effect :bradycardia ,
                                                                      :congestiveHeartFailure ;
                                OpenPVSignal:refers_to_drug :dronedarone ;
                                mp:citation "In the summary of the product characteristics of dronedarone, the most common adverse reactions (experienced by at least 10% of the patients) include gastrointestinal disorders such as diarrhoea, nausea, vomiting, abdominal pain and dysgeusia, cardiac disorders such as congestive heart failure and bradycardia, skin disorders such as rashes and pruritus, general disorders such as fatigue and asthenia, and liver function test abnormalities." ;
                                rdfs:label "dronedarone and cardiac disorders" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#dronedaroneAndGastrointestinalDisorders
:dronedaroneAndGastrointestinalDisorders rdf:type owl:NamedIndividual ,
                                                  OpenPVSignal:Warning_Information ;
                                         OpenPVSignal:refers_to_adverse_effect :abdominalPain ,
                                                                               :diarrhoea ,
                                                                               :dysgeusia ,
                                                                               :nausea ,
                                                                               :vomiting ;
                                         OpenPVSignal:refers_to_drug :dronedarone ;
                                         mp:citation "In the summary of the product characteristics of dronedarone, the most common adverse reactions (experienced by at least 10% of the patients) include gastrointestinal disorders such as diarrhoea, nausea, vomiting, abdominal pain and dysgeusia, cardiac disorders such as congestive heart failure and bradycardia, skin disorders such as rashes and pruritus, general disorders such as fatigue and asthenia, and liver function test abnormalities." ;
                                         rdfs:label "dronedarone and gastrointestinal disorders" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#dronedaroneAndGeneralDisorders
:dronedaroneAndGeneralDisorders rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Warning_Information ;
                                OpenPVSignal:refers_to_adverse_effect :asthenia ,
                                                                      :fatigue ,
                                                                      :liverFunctionTestAbnormalities ;
                                OpenPVSignal:refers_to_drug :dronedarone ;
                                OpenPVSignal:has_content "In the summary of the product characteristics of dronedarone, the most common adverse reactions (experienced by at least 10% of the patients) include gastrointestinal disorders such as diarrhoea, nausea, vomiting, abdominal pain and dysgeusia, cardiac disorders such as congestive heart failure and bradycardia, skin disorders such as rashes and pruritus, general disorders such as fatigue and asthenia, and liver function test abnormalities." ;
                                rdfs:label "dronedarone and general disorders" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#dronedaroneAndSkinDisorders
:dronedaroneAndSkinDisorders rdf:type owl:NamedIndividual ,
                                      OpenPVSignal:Warning_Information ;
                             OpenPVSignal:refers_to_adverse_effect :pruritus ,
                                                                   :rash ;
                             OpenPVSignal:refers_to_drug :dronedarone ;
                             mp:citation "In the summary of the product characteristics of dronedarone, the most common adverse reactions (experienced by at least 10% of the patients) include gastrointestinal disorders such as diarrhoea, nausea, vomiting, abdominal pain and dysgeusia, cardiac disorders such as congestive heart failure and bradycardia, skin disorders such as rashes and pruritus, general disorders such as fatigue and asthenia, and liver function test abnormalities." ;
                             rdfs:label "dronedarone and skin disorders" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#drugInteraction
:drugInteraction rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "T887XXA" ;
                 OpenPVSignal:has_MedDRA_code 10013710 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Drug interaction" ;
                 rdfs:label "drug interaction" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#drugLevelDecreased
:drugLevelDecreased rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_ICD_code "G2401" ;
                    OpenPVSignal:has_MedDRA_code 10013718 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Drug level decreased" ;
                    rdfs:label "drug level decreased" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#dysgeusia
:dysgeusia rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "R432" ;
           OpenPVSignal:has_MedDRA_code 10013911 ;
           OpenPVSignal:has_MedDRA_prefered_term "Dysgeusia" ;
           rdfs:label "Dysgeusia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#dyspepsia
:dyspepsia rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code " K30" ;
           OpenPVSignal:has_MedDRA_code 10013946 ;
           OpenPVSignal:has_MedDRA_prefered_term "Dyspepsia" ;
           rdfs:label "dyspepsia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#dyspnoea
:dyspnoea rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R060" ;
          OpenPVSignal:has_MedDRA_code 10013968 ;
          OpenPVSignal:has_MedDRA_prefered_term "Dyspnoea" ;
          rdfs:label "dyspnoea" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#dysuria
:dysuria rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "R30.0" ;
         OpenPVSignal:has_MedDRA_code 10013990 ;
         OpenPVSignal:has_MedDRA_prefered_term "Dysuria" ;
         rdfs:label "Dysuria" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#emotionalLability
:emotionalLability rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "R4586" ;
                   OpenPVSignal:has_MedDRA_code 10014555 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Emotional lability" ;
                   rdfs:label "emotional lability" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#enalapril
:enalapril rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C09AA02" ,
                                     "C09BA02" ,
                                     "C09BB02" ,
                                     "C09BB06" ;
           rdfs:label "enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#esomeprazole
:esomeprazole rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "A02BC05" ,
                                        "A02BD06" ,
                                        "M01AE52" ;
              rdfs:label "esomeprazole" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#estrogen
:estrogen rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "G03FA" ;
          rdfs:label "estrogen" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#eyeAbnormality
:eyeAbnormality rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "R609" ;
                OpenPVSignal:has_MedDRA_code 10015903 ;
                OpenPVSignal:has_MedDRA_prefered_term "Eye abnormality" ;
                rdfs:label "eye abnormality" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#eyePain
:eyePain rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "H5710" ;
         OpenPVSignal:has_MedDRA_code 10015958 ;
         OpenPVSignal:has_MedDRA_prefered_term "Eye pain" ;
         rdfs:label "eye pain" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#fatigue
:fatigue rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "R5383" ;
         OpenPVSignal:has_MedDRA_code 10016256 ;
         OpenPVSignal:has_MedDRA_prefered_term "Fatigue" ;
         rdfs:label "fatigue" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#finasteride
:finasteride rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "D11AX10" ,
                                       "G04CA51" ,
                                       "G04CB01" ;
             rdfs:label "finasteride" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#fishOil
:fishOil rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Drug ;
         OpenPVSignal:has_ATC_code "C10AX06 " ;
         rdfs:label "fish oil" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#flatulence
:flatulence rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "R143" ;
            OpenPVSignal:has_MedDRA_code 10016766 ;
            OpenPVSignal:has_MedDRA_prefered_term "Flatulence" ;
            rdfs:label "flatulence" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#furosemide
:furosemide rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C03CA01" ,
                                      "C03CB01" ,
                                      "C03EB01" ,
                                      "G01AE10" ;
            rdfs:label "furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#gabapentin
:gabapentin rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N03AX12" ;
            rdfs:label "gabapentin" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#gaitAbnormal
:gaitAbnormal rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "R26" ;
              OpenPVSignal:has_MedDRA_code 10017573 ;
              OpenPVSignal:has_MedDRA_prefered_term "Gait abnormal" ;
              rdfs:label "gait abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#glaucoma
:glaucoma rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "H40" ;
          OpenPVSignal:has_MedDRA_code 10018304 ;
          OpenPVSignal:has_MedDRA_prefered_term "Glaucoma" ;
          rdfs:label "glaucoma" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#glibenclamide
:glibenclamide rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "A10BB01" ;
               rdfs:label "glibenclamide" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#glipizide
:glipizide rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "A10BB07" ;
           rdfs:label "glipizide" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#glycerylTrinitrate
:glycerylTrinitrate rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Drug ;
                    OpenPVSignal:has_ATC_code "C01DA02" ,
                                              "C05AE01" ;
                    rdfs:label "glyceryl trinitrate" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hallucination
:hallucination rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "R443" ;
               OpenPVSignal:has_MedDRA_code 10019063 ;
               OpenPVSignal:has_MedDRA_prefered_term "Hallucination" ;
               rdfs:label "hallucination" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#haloVision
:haloVision rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "H53.19" ;
            OpenPVSignal:has_MedDRA_code 10019099 ;
            OpenPVSignal:has_MedDRA_prefered_term "Halo vision" ;
            rdfs:label "halo vision" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#headache
:headache rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R51" ;
          OpenPVSignal:has_MedDRA_code 10019211 ;
          OpenPVSignal:has_MedDRA_prefered_term "Headache" ;
          rdfs:label "headache" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hearingDecreased
:hearingDecreased rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "H9190" ;
                  OpenPVSignal:has_MedDRA_code 10019241 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Hearing decreased" ;
                  rdfs:label "hearing decreased" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hemianopiaHomonymous
:hemianopiaHomonymous rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Adverse_Effect ;
                      OpenPVSignal:has_ICD_code "H53.469" ;
                      OpenPVSignal:has_MedDRA_code 10019456 ;
                      OpenPVSignal:has_MedDRA_prefered_term "Hemianopia homonymous" ;
                      rdfs:label "hemianopia homonymous" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#heparin
:heparin rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Drug ;
         OpenPVSignal:has_ATC_code "B01AB01" ,
                                   "B01AB51" ,
                                   "C05BA03" ,
                                   "C05BA53" ,
                                   "S01XA14" ;
         rdfs:label "heparin" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hepaticEnzymesIncreased
:hepaticEnzymesIncreased rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Adverse_Effect ;
                         OpenPVSignal:has_ICD_code "R945" ;
                         OpenPVSignal:has_MedDRA_code 10060795 ;
                         OpenPVSignal:has_MedDRA_prefered_term "Hepatic enzyme increased" ;
                         rdfs:label "hepatic enzymes increased" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hydralazine
:hydralazine rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C02DB02" ,
                                       "C02LG02" ;
             rdfs:label "hydralazine" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hydrochlorothiazide
:hydrochlorothiazide rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug ;
                     OpenPVSignal:has_ATC_code "C03AA03" ,
                                               "C03AB03" ,
                                               "C03AX01" ,
                                               "C03EA01" ,
                                               "C09DX01" ,
                                               "C09DX03" ,
                                               "C09XA52" ,
                                               "C09XA54" ,
                                               "G01AE10" ;
                     rdfs:label "hydrochlorothiazide" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hyperammonaemia
:hyperammonaemia rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "E7220" ;
                 OpenPVSignal:has_MedDRA_code 10020575 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Hyperammonaemia" ;
                 rdfs:label "hyperammonaemia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hyperglycaemia
:hyperglycaemia rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "R739" ;
                OpenPVSignal:has_MedDRA_code 10020635 ;
                OpenPVSignal:has_MedDRA_prefered_term "Hyperglycaemia" ;
                rdfs:label "hyperglycaemia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hyperkalaemia
:hyperkalaemia rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "E875" ;
               OpenPVSignal:has_MedDRA_code 10020646 ;
               OpenPVSignal:has_MedDRA_prefered_term "Hyperkalaemia" ;
               rdfs:label "hyperkalaemia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hypertension
:hypertension rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "I10" ;
              OpenPVSignal:has_MedDRA_code 10020772 ;
              OpenPVSignal:has_MedDRA_prefered_term "Hypertension" ;
              rdfs:label "hypertension" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hypoaesthesia
:hypoaesthesia rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "R201" ;
               OpenPVSignal:has_MedDRA_code 10020937 ;
               OpenPVSignal:has_MedDRA_prefered_term "Hypoaesthesia" ;
               rdfs:label "hypoaesthesia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hypotension
:hypotension rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "I959" ;
             OpenPVSignal:has_MedDRA_code 10021097 ;
             OpenPVSignal:has_MedDRA_prefered_term "Hypotension" ;
             rdfs:label "hypotension" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#insomnia
:insomnia rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "G470" ;
          OpenPVSignal:has_MedDRA_code 10022437 ;
          OpenPVSignal:has_MedDRA_prefered_term "Insomnia" ;
          rdfs:label "insomnia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#insulin
:insulin rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Drug ;
         OpenPVSignal:has_ATC_code "A10AD01" ;
         rdfs:label "insulin" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#insulinGlargine
:insulinGlargine rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Drug ;
                 OpenPVSignal:has_ATC_code "A10AE04" ;
                 rdfs:label "insulin glargine" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#insulinLispro
:insulinLispro rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "A10AB04" ,
                                         "A10AC04" ,
                                         "A10AD04" ;
               rdfs:label "insulin lispro" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#introductionContent
:introductionContent rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Introduction ;
                     mp:references :Ref.1 ,
                                   :Ref.2 ;
                     OpenPVSignal:has_content """Dronedarone has been shown to prevent atrial fibrillation (AF) or restore normal sinus rhythm
 
depending on the model used. The drug can also prevent ventricular tachycardia and ventricular fibrillation in several animal models. These effects most likely result from its electrophysiological properties belonging to all four Vaughan-Williams classes. Dronedarone is a multichannel blocker inhibiting the potassium currents and thus prolonging cardiac action potential and refractory periods. It also inhibits the sodium currents and the calcium currents. It also non-competitively antagonises adrenergic activities. It is indicated for the maintenance of sinus rhythm after successful cardioversion in adult clinically stable patients with paroxysmal or persistent atrial fibrillation. The most common adverse reactions (experienced by at least 10% of the patients) include gastrointestinal disorders such as diarrhoea, nausea, vomiting, abdominal pains and dysgeusia, cardiac disorders such as congestive heart failure and bradycardia, skin disorders such as rashes and pruritus, general disorders such as fatigue and asthenia and liver function test abnormalities.1
Vision abnormal is a non-specific term which refers to a change, usually a deterioration, in visual function or perception.2 In WHO-ART, vision abnormal is a preferred term (PT) which encompasses many included terms (ITs) consisting of amblyopia (reduced vision in an apparently normal eye), asthenopia (eye strain), depth perception difficulty, metaporphopsia (a specific type of distorted vision), refractive error, tired eye, vision abnormal, vision abnormal aggravated, vision blurred, vision decreased, visual acuity alteration, visual disturbance and visual impairment.                      """ ;
                     rdfs:label "introduction content" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#isosorbideDinitrate
:isosorbideDinitrate rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug ;
                     OpenPVSignal:has_ATC_code "C01DA08" ,
                                               "C01DA58" ,
                                               "C05AE02" ;
                     rdfs:label "isosorbide dinitrate" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#labetalol
:labetalol rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C07AG01" ,
                                     "C07BG01" ,
                                     "C07CG01" ;
           rdfs:label "labetalol" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#lacrimationAbnormal
:lacrimationAbnormal rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_MedDRA_code 10023640 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Lacrimation abnormal" ;
                     rdfs:label "lacrimation abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#lansoprazole
:lansoprazole rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "A02BC03" ,
                                        "A02BC53" ,
                                        "A02BD02" ,
                                        "A02BD03" ,
                                        "A02BD07" ,
                                        "A02BD09" ,
                                        "A02BD10" ;
              rdfs:label "lansoprazole" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#leg_pain
:leg_pain rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_MedDRA_code 10024130 ;
          OpenPVSignal:has_MedDRA_prefered_term "Leg pain" ;
          rdfs:label "leg pain" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#lercanidipine
:lercanidipine rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "C08CA13" ,
                                         "C09BB02" ,
                                         "C09DB08" ;
               rdfs:label "lercanidipine" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#levothyroxine
:levothyroxine rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "H03AA01" ;
               rdfs:label "levothyroxine" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#lisinopril
:lisinopril rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C09AA03" ,
                                      "C09BA03" ,
                                      "C09BB03" ,
                                      "C10BX07" ;
            rdfs:label "lisinopril" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#liverFatty
:liverFatty rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "K76.0" ;
            OpenPVSignal:has_MedDRA_code 10016261 ;
            OpenPVSignal:has_MedDRA_prefered_term "Fatty liver" ;
            rdfs:label "fatty liver" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#liverFunctionTestAbnormalities
:liverFunctionTestAbnormalities rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Adverse_Effect ;
                                OpenPVSignal:has_ICD_code "R94.5" ;
                                OpenPVSignal:has_MedDRA_code 10017475 ;
                                OpenPVSignal:has_MedDRA_prefered_term "Function liver abnormal" ;
                                rdfs:label "liver function abnormalities" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#lovastatin
:lovastatin rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C10AA02" ,
                                      "C10BA01" ;
            rdfs:label "lovastatin" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#medicationError
:medicationError rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "M62838" ;
                 OpenPVSignal:has_MedDRA_code 10027091 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Medication error" ;
                 rdfs:label "medication error" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#metamorphopsia
:metamorphopsia rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_MedDRA_code 10063341 ;
                OpenPVSignal:has_MedDRA_prefered_term "Metamorphopsia" ;
                rdfs:label "metamorphopsia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#metformin
:metformin rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "A10BA02" ,
                                     "A10BD02" ,
                                     "A10BD03" ,
                                     "A10BD05" ,
                                     "A10BD07" ,
                                     "A10BD08" ,
                                     "A10BD10" ,
                                     "A10BD11" ,
                                     "A10BD13" ,
                                     "A10BD14" ,
                                     "A10BD15" ,
                                     "A10BD16" ,
                                     "A10BD17" ,
                                     "A10BD18" ,
                                     "A10BD20" ;
           rdfs:label "metformin" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#methyldopa
:methyldopa rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C02AB" ,
                                      "C02AB01" ,
                                      "C02AB02 " ;
            rdfs:label "methyldopa" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#metoprolol
:metoprolol rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C07AB02" ,
                                      "C07AB52" ,
                                      "C07BB02" ,
                                      "C07BB52" ,
                                      "C07CB02" ,
                                      "C07FB02" ;
            rdfs:label "metoprolol" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#muscleWeakness
:muscleWeakness rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "M628" ;
                OpenPVSignal:has_MedDRA_code 10028372 ;
                OpenPVSignal:has_MedDRA_prefered_term "Muscular weakness" ;
                rdfs:label "muscle weakness" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#myalgia
:myalgia rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "M791" ;
         OpenPVSignal:has_MedDRA_code 10028411 ;
         OpenPVSignal:has_MedDRA_prefered_term "Myalgia" ;
         rdfs:label "myalgia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#nausea
:nausea rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "R11" ;
        OpenPVSignal:has_MedDRA_code 10028813 ;
        OpenPVSignal:has_MedDRA_prefered_term "Nausea" ;
        rdfs:label "nausea" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#nebivolol
:nebivolol rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C07AB12" ,
                                     "C07BB12" ,
                                     "C07FB12" ;
           rdfs:label "nebivolol" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#nervousness
:nervousness rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "R450" ;
             OpenPVSignal:has_MedDRA_code 10029216 ;
             OpenPVSignal:has_MedDRA_prefered_term "Nervousness" ;
             rdfs:label "nervousness" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#neuropathyPeripheral
:neuropathyPeripheral rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Adverse_Effect ;
                      OpenPVSignal:has_ICD_code "G9009" ;
                      OpenPVSignal:has_MedDRA_code 10029331 ;
                      OpenPVSignal:has_MedDRA_prefered_term "Neuropathy peripheral" ;
                      rdfs:label "neuropathy peripheral" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#nicotinic_acid
:nicotinic_acid rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "C04AC01" ;
                rdfs:label "nicotinic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#nifedipine
:nifedipine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C08CA05" ,
                                      "C08CA55" ,
                                      "C08GA01" ;
            rdfs:label "nifedipine" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#ocularHaemorrhage
:ocularHaemorrhage rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_MedDRA_code 10030039 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Ocular haemorrhage" ;
                   rdfs:label "ocular haemorrhage" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#oedema
:oedema rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "R609" ;
        OpenPVSignal:has_MedDRA_code 10030095 ;
        OpenPVSignal:has_MedDRA_prefered_term "Oedema" ;
        rdfs:label "oedema" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#oedemaPeripheral
:oedemaPeripheral rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "R600 " ;
                  OpenPVSignal:has_MedDRA_code 10030124 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Oedema peripheral" ;
                  rdfs:label "oedema peripheral" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#oliguria
:oliguria rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R34" ;
          OpenPVSignal:has_MedDRA_code 10030302 ;
          OpenPVSignal:has_MedDRA_prefered_term "Oliguria" ;
          rdfs:label "oliguria" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#omega-3-acidEthylEster
:omega-3-acidEthylEster rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Drug ;
                        OpenPVSignal:has_ATC_code "C10AX06" ;
                        rdfs:label "omega 3 acid ethylester" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#opticAtrophy
:opticAtrophy rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "H47.2" ;
              OpenPVSignal:has_MedDRA_code 10030910 ;
              OpenPVSignal:has_MedDRA_prefered_term "Optic atrophy" ;
              rdfs:label "optic atrophy" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#opticNeuritis
:opticNeuritis rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "H46.9" ;
               OpenPVSignal:has_MedDRA_code 10030942 ;
               OpenPVSignal:has_MedDRA_prefered_term "optic neuritis" ;
               rdfs:label "optic neuritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#oscillopsia
:oscillopsia rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "H55.00" ;
             OpenPVSignal:has_MedDRA_code 10052087 ;
             OpenPVSignal:has_MedDRA_prefered_term "Oscillopsia" ;
             rdfs:label "Oscillopsia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#pain
:pain rdf:type owl:NamedIndividual ,
               OpenPVSignal:Adverse_Effect ;
      OpenPVSignal:has_ICD_code "G891" ;
      OpenPVSignal:has_MedDRA_code 10033371 ;
      OpenPVSignal:has_MedDRA_prefered_term "Pain" ;
      rdfs:label "pain" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#painInExtremity
:painInExtremity rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "M79.606" ;
                 OpenPVSignal:has_MedDRA_code 10033425 ;
                 OpenPVSignal:has_MedDRA_prefered_term "pain in extremity" ;
                 rdfs:label "pain in extremity" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#pantoprazole
:pantoprazole rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "A02BC02" ,
                                        "A02BD04" ,
                                        "A02BD11" ;
              rdfs:label "pantoprazole" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#papilloedema
:papilloedema rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_MedDRA_code 10033712 ;
              OpenPVSignal:has_MedDRA_prefered_term "Papilloedema" ;
              rdfs:label "papilloedema" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#paracetamol
:paracetamol rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "N02BE01" ;
             rdfs:label "paracetamol" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#paraesthesia
:paraesthesia rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "R202" ;
              OpenPVSignal:has_MedDRA_code 10033775 ;
              OpenPVSignal:has_MedDRA_prefered_term "Paraesthesia" ;
              rdfs:label "paraesthesia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#phenprocoumon
:phenprocoumon rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "B01AA04" ;
               rdfs:label "phenprocoumon" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#photophobia
:photophobia rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "H531" ;
             OpenPVSignal:has_MedDRA_code 10034960 ;
             OpenPVSignal:has_MedDRA_prefered_term "Photophobia" ;
             rdfs:label "Photophobia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#photopsia
:photopsia rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "H53.19" ;
           OpenPVSignal:has_MedDRA_code 10034962 ;
           OpenPVSignal:has_MedDRA_prefered_term "Photopsia" ;
           rdfs:label "Photopsia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#photosensitivityReaction
:photosensitivityReaction rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Adverse_Effect ;
                          OpenPVSignal:has_ICD_code "L568" ;
                          OpenPVSignal:has_MedDRA_code 10034972 ;
                          OpenPVSignal:has_MedDRA_prefered_term "Photosensitivity reaction" ;
                          rdfs:label "photosensitivity reaction" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#pleuralEffusion
:pleuralEffusion rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "J90" ;
                 OpenPVSignal:has_MedDRA_code 10035598 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Pleural effusion" ;
                 rdfs:label "pleural effusion" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#pneumonia
:pneumonia rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "J158" ;
           OpenPVSignal:has_MedDRA_code 10035664 ;
           OpenPVSignal:has_MedDRA_prefered_term "Pneumonia" ;
           rdfs:label "pneumonia" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#polyneuropathy
:polyneuropathy rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "G62.9" ;
                OpenPVSignal:has_MedDRA_code 10036105 ;
                OpenPVSignal:has_MedDRA_prefered_term "Polyneuropathy" ;
                rdfs:label "Polyneuropathy" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#potassium
:potassium rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "B05XA17" ,
                                     "C03AB01" ,
                                     "C03AB02" ,
                                     "C03AB03" ,
                                     "C03AB04" ,
                                     "C03AB05" ,
                                     "C03AB06" ,
                                     "C03AB07" ,
                                     "C03AB08" ,
                                     "C03AB09" ,
                                     "C03BB02" ,
                                     "C03BB03" ,
                                     "C03BB04" ,
                                     "C03BB05" ,
                                     "C03BB07" ,
                                     "C03CB01" ,
                                     "C03CB02" ;
           rdfs:label "potassium" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#pravastatin
:pravastatin rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C10AA03" ,
                                       "C10BA03" ,
                                       "C10BX02" ;
             rdfs:label "pravastatin" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#product_label_issue
:product_label_issue rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_MedDRA_code 10069289 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Product label issue" ;
                     rdfs:label "product label issue" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#product_quality_issue
:product_quality_issue rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect ;
                       OpenPVSignal:has_MedDRA_code 10069327 ;
                       OpenPVSignal:has_MedDRA_prefered_term "Product quality issue" ;
                       rdfs:label "product quality issue" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#prothrombinDecreased
:prothrombinDecreased rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Adverse_Effect ;
                      OpenPVSignal:has_ICD_code "R791" ;
                      OpenPVSignal:has_MedDRA_code 10037050 ;
                      OpenPVSignal:has_MedDRA_prefered_term "Prothrombin level decreased" ;
                      rdfs:label "prothrombin decreased" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#pruritus
:pruritus rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "L29.9" ;
          OpenPVSignal:has_MedDRA_code 10037087 ;
          OpenPVSignal:has_MedDRA_prefered_term "Pruritus" ;
          rdfs:label "Pruritus" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#pulmonaryDisorders
:pulmonaryDisorders rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_MedDRA_code 10025082 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Lung Disorder" ;
                    rdfs:label "pulmonary disorder" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#pupillaryReflexImpaired
:pupillaryReflexImpaired rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Adverse_Effect ;
                         OpenPVSignal:has_ICD_code "R29.2" ;
                         OpenPVSignal:has_MedDRA_code 10037532 ;
                         OpenPVSignal:has_MedDRA_prefered_term "pupillary reflex impaired" ;
                         rdfs:label "pupillary reflex impaired" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#purpura
:purpura rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "D692" ;
         OpenPVSignal:has_MedDRA_code 10037549 ;
         OpenPVSignal:has_MedDRA_prefered_term "Purpura" ;
         rdfs:label "purpura" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#pvSignal
:pvSignal rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Signal ;
          OpenPVSignal:Free_text_reporting_element :DiscussionAndConclusion ,
                                                   :ReportsInVigibase ,
                                                   :SummaryContent ,
                                                   :introductionContent ,
                                                   :vision_abnormal_pathophysiology ;
          OpenPVSignal:is_supported_by_individual_case_report :VigibaseReport1 ,
                                                              :VigibaseReport10 ,
                                                              :VigibaseReport11 ,
                                                              :VigibaseReport12 ,
                                                              :VigibaseReport13 ,
                                                              :VigibaseReport14 ,
                                                              :VigibaseReport15 ,
                                                              :VigibaseReport16 ,
                                                              :VigibaseReport17 ,
                                                              :VigibaseReport18 ,
                                                              :VigibaseReport19 ,
                                                              :VigibaseReport2 ,
                                                              :VigibaseReport20 ,
                                                              :VigibaseReport21 ,
                                                              :VigibaseReport22 ,
                                                              :VigibaseReport23 ,
                                                              :VigibaseReport24 ,
                                                              :VigibaseReport25 ,
                                                              :VigibaseReport26 ,
                                                              :VigibaseReport27 ,
                                                              :VigibaseReport28 ,
                                                              :VigibaseReport29 ,
                                                              :VigibaseReport3 ,
                                                              :VigibaseReport30 ,
                                                              :VigibaseReport31 ,
                                                              :VigibaseReport32 ,
                                                              :VigibaseReport33 ,
                                                              :VigibaseReport34 ,
                                                              :VigibaseReport35 ,
                                                              :VigibaseReport4 ,
                                                              :VigibaseReport5 ,
                                                              :VigibaseReport6 ,
                                                              :VigibaseReport7 ,
                                                              :VigibaseReport8 ,
                                                              :VigibaseReport9 ;
          OpenPVSignal:is_supported_by_statistical_entity :IC025ValueOfDronedaroneAndVisualImpaired ,
                                                          :ICValueOfDronedaroneAndVisualImpaired ,
                                                          :OverallReportsInVigibaseForDronedaroneAndVisionAbnormal ,
                                                          :ReportsFromCanada ,
                                                          :ReportsFromGermany ,
                                                          :ReportsFromItaly ,
                                                          :ReportsFromSweden ,
                                                          :ReportsFromUnitedKingdom ,
                                                          :ReportsFromUnitedStates ,
                                                          :ReportsWithDronedaroneAsTheOnlySuspect ,
                                                          :reportsWithNoRecoveryAsOutcome ,
                                                          :reports_with_age_info ,
                                                          :reports_with_no_recovery_with_negative_dechallenge ,
                                                          :reports_with_time_to_onset_info ,
                                                          <http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#reportsWithrecovering/recoveredAsOutcome> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#reports_with_recovering/recovered_without_withdrawl> ;
          OpenPVSignal:refers_to_adverse_effect :visionAbnormal ;
          OpenPVSignal:refers_to_drug :dronedarone ;
          mp:supportedByData :DIONYSOSTrial ,
                             :amiodarone_as_known_cause_of_visual_disturbance ,
                             :dabigatran_and_dronaderone_interaction ,
                             :digoxin_and_vision_abnormal ,
                             :dronedaroneAndCardiacDisorders ,
                             :dronedaroneAndGastrointestinalDisorders ,
                             :dronedaroneAndGeneralDisorders ,
                             :dronedaroneAndSkinDisorders ;
          OpenPVSignal:initially_identified_on "01/12/2014" ;
          rdfs:label "pv signal" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#qualityOfLifeDecreased
:qualityOfLifeDecreased rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_MedDRA_code 10067620 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Quality of life decreased" ;
                        rdfs:label "quality of life decreased" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#ramipril
:ramipril rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "C09AA05" ,
                                    "C09BA05" ,
                                    "C09BB05" ,
                                    "C09BB07" ,
                                    "C10BX04" ,
                                    "C10BX06" ;
          rdfs:label "ramipril" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#rash
:rash rdf:type owl:NamedIndividual ,
               OpenPVSignal:Adverse_Effect ;
      OpenPVSignal:has_ICD_code "R21" ;
      OpenPVSignal:has_MedDRA_code 10037844 ;
      OpenPVSignal:has_MedDRA_prefered_term "Rash" ;
      rdfs:label "rash" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#rashErythematous
:rashErythematous rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "L53.9" ,
                                            "L539" ;
                  OpenPVSignal:has_MedDRA_code 10037855 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Rash erythematous" ;
                  rdfs:label "rash erythematous" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#rashPsoriaform
:rashPsoriaform rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "L30.8" ;
                OpenPVSignal:has_MedDRA_code 10037885 ;
                OpenPVSignal:has_MedDRA_prefered_term "Rash psoriaform" ;
                rdfs:label "rash psoriaform" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#refractiveError
:refractiveError rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "H52.7" ;
                 OpenPVSignal:has_MedDRA_code 10038268 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Refractive errors NOS" ;
                 rdfs:label "refractive error" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#renalFailureAcute
:renalFailureAcute rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "N179" ;
                   OpenPVSignal:has_MedDRA_code 10069339 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Acute kidney injury" ;
                   rdfs:label "renal failure acute" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#renalFailureChronic
:renalFailureChronic rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_ICD_code "N189" ;
                     OpenPVSignal:has_MedDRA_code 10064848 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Chronic kidney disease" ;
                     rdfs:label "renal failure chronic" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#reportsWithNoRecoveryAsOutcome
:reportsWithNoRecoveryAsOutcome rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Reports_group ;
                                OpenPVSignal:is_subgroup_of :OverallReportsInVigibaseForDronedaroneAndVisionAbnormal ;
                                OpenPVSignal:has_count 4 ;
                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
                                rdfs:label "reports with no recovery as outcome" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#reports_with_age_info
:reports_with_age_info rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Reports_group ;
                       OpenPVSignal:is_subgroup_of :OverallReportsInVigibaseForDronedaroneAndVisionAbnormal ;
                       OpenPVSignal:has_count 30 ;
                       OpenPVSignal:has_max_age 83 ;
                       OpenPVSignal:has_median_age 70 ;
                       OpenPVSignal:has_min_age 51 ;
                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                       rdfs:label "reports with age info" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#reports_with_no_recovery_with_negative_dechallenge
:reports_with_no_recovery_with_negative_dechallenge rdf:type owl:NamedIndividual ,
                                                             OpenPVSignal:Reports_group ;
                                                    OpenPVSignal:is_subgroup_of :OverallReportsInVigibaseForDronedaroneAndVisionAbnormal ;
                                                    OpenPVSignal:has_count 1 ;
                                                    OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                    OpenPVSignal:refers_to_dechallenge_outcome "negative - condition still applied" ;
                                                    rdfs:label "reports with no recovery with negative dechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#reports_with_time_to_onset_info
:reports_with_time_to_onset_info rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Reports_group ;
                                 OpenPVSignal:is_subgroup_of :OverallReportsInVigibaseForDronedaroneAndVisionAbnormal ;
                                 OpenPVSignal:time_to_onset :timeToOnsetContent ;
                                 OpenPVSignal:has_count 7 ;
                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                 rdfs:label "reports with time to onset info" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#rigors
:rigors rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_MedDRA_code 10039177 ;
        OpenPVSignal:has_MedDRA_prefered_term "Rigors" ;
        rdfs:label "rigors" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#risedronicAcid
:risedronicAcid rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "M05BA07 " ;
                rdfs:label "risedronic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#rivaroxaban
:rivaroxaban rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "B01AF01" ;
             rdfs:label "rivaroxaban" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#rosuvastatin
:rosuvastatin rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "C10AA07" ,
                                        "C10BA06" ,
                                        "C10BX05" ,
                                        "C10BX07" ,
                                        "C10BX09" ,
                                        "C10BX10" ,
                                        "G01AE10" ;
              rdfs:label "rosuvastatin" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#salbutamol
:salbutamol rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "R03AC02" ,
                                      "R03AK04" ,
                                      "R03AL02" ,
                                      "R03CC02" ;
            rdfs:label "salbutamol" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#scotoma
:scotoma rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "H53.413" ;
         OpenPVSignal:has_MedDRA_code 10039729 ;
         OpenPVSignal:has_MedDRA_prefered_term "Scotoma" ;
         rdfs:label "Scotoma" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#silodosin
:silodosin rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "G04CA04" ;
           rdfs:label "silodosin" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#simvastatin
:simvastatin rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "A10BH51" ,
                                       "C10AA01" ,
                                       "C10BA02" ,
                                       "C10BA04" ,
                                       "C10BX01" ,
                                       "C10BX04" ;
             rdfs:label "simvastatin" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#skeletalPain
:skeletalPain rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "G4763" ;
              OpenPVSignal:has_MedDRA_code 10006002 ;
              OpenPVSignal:has_MedDRA_prefered_term "Bone pain" ;
              rdfs:label "skeletal pain" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#skinDiscolouration
:skinDiscolouration rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_ICD_code "L819" ;
                    OpenPVSignal:has_MedDRA_code 10040829 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Skin discolouration" ;
                    rdfs:label "skin discolouration" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#skinDisorder
:skinDisorder rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "L98.9" ;
              OpenPVSignal:has_MedDRA_code 10040831 ;
              OpenPVSignal:has_MedDRA_prefered_term "Skin disorder" ;
              rdfs:label "skin disorder" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#skinExfoliation
:skinExfoliation rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "L491" ;
                 OpenPVSignal:has_MedDRA_code 10040844 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Skin exfoliation" ;
                 rdfs:label "skin exfoliation" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#sleepDisorder
:sleepDisorder rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "G479" ;
               OpenPVSignal:has_MedDRA_code 10040984 ;
               OpenPVSignal:has_MedDRA_prefered_term "Sleep disorder" ;
               rdfs:label "sleep disorder" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#sotalol
:sotalol rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Drug ;
         OpenPVSignal:has_ATC_code "C07AA07" ,
                                   "C07AA57" ,
                                   "C07BA07" ;
         rdfs:label "sotalol" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#speechDisorder
:speechDisorder rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "F809" ;
                OpenPVSignal:has_MedDRA_code 10041466 ;
                OpenPVSignal:has_MedDRA_prefered_term "Speech disorder" ;
                rdfs:label "speech disorder" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#spironolactone
:spironolactone rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "C03DA01" ;
                rdfs:label "spironolactone" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#sweatingIncreased
:sweatingIncreased rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "R61" ;
                   OpenPVSignal:has_MedDRA_code 10020642 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Hyperhidrosis" ;
                   rdfs:label "sweating increased" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#tachycardiaSupraventricular
:tachycardiaSupraventricular rdf:type owl:NamedIndividual ,
                                      OpenPVSignal:Adverse_Effect ;
                             OpenPVSignal:has_ICD_code "I47.1" ;
                             OpenPVSignal:has_MedDRA_code 10042604 ;
                             OpenPVSignal:has_MedDRA_prefered_term "Supraventricular tachycardia" ;
                             rdfs:label "tachychardia supraventricular" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#tadalafil
:tadalafil rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "G04BE08" ;
           rdfs:label "tadalafil" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#tension_headache
:tension_headache rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_MedDRA_code 10043269 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Tension headache" ;
                  rdfs:label "tension headache" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#terazosin
:terazosin rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "G04CA03" ;
           rdfs:label "terazosin" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#testosterone
:testosterone rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "G03BA03" ,
                                        "G03EA02" ;
              rdfs:label "testosterone" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#therapeuticResponseIncreased
:therapeuticResponseIncreased rdf:type owl:NamedIndividual ,
                                       OpenPVSignal:Adverse_Effect ;
                              OpenPVSignal:has_ICD_code "F959" ;
                              OpenPVSignal:has_MedDRA_code 10043415 ;
                              OpenPVSignal:has_MedDRA_prefered_term "Therapeutic response increased" ;
                              rdfs:label "therapeutic response increased" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#thrombosis
:thrombosis rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "I749" ;
            OpenPVSignal:has_MedDRA_code 10043607 ;
            OpenPVSignal:has_MedDRA_prefered_term "Thrombosis" ;
            rdfs:label "thrombosis" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#thrombosisCoronary
:thrombosisCoronary rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_MedDRA_code 10043622 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Thrombosis coronary" ;
                    rdfs:label "thrombosis coronary" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#thrombosis_retinal_vein
:thrombosis_retinal_vein rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Adverse_Effect ;
                         OpenPVSignal:has_MedDRA_code 10043638 ;
                         OpenPVSignal:has_MedDRA_prefered_term "Thrombosis retinal vein" ;
                         rdfs:label "thrombosis retinal vein" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#thyroidDisorder
:thyroidDisorder rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "C73" ;
                 OpenPVSignal:has_MedDRA_code 10043709 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Thyroid Disorder" ;
                 rdfs:label "thyroid disorder" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#timeToOnsetContent
:timeToOnsetContent rdf:type owl:NamedIndividual ,
                             <http://www.w3.org/2006/time#DurationDescription> ;
                    OpenPVSignal:has_content "Time to onset was reported in seven of the reports. It ranged from the same day the drug was started (in three cases) to about seven months." ;
                    rdfs:label "time to onset content" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#tinnitus
:tinnitus rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "H931" ;
          OpenPVSignal:has_MedDRA_code 10043882 ;
          OpenPVSignal:has_MedDRA_prefered_term "Tinnitus" ;
          rdfs:label "tinnitus" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#tiredEye
:tiredEye rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "H57.9" ;
          OpenPVSignal:has_MedDRA_code 10043887 ;
          OpenPVSignal:has_MedDRA_prefered_term "Tired eye" ;
          rdfs:label "tired eye" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#tremor
:tremor rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "R251" ;
        OpenPVSignal:has_MedDRA_code 10044565 ;
        OpenPVSignal:has_MedDRA_prefered_term "Tremor" ;
        rdfs:label "tremor" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#ubidecarenone
:ubidecarenone rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "C01EB09" ;
               rdfs:label "ubidecarenone" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#urinaryIncontinence
:urinaryIncontinence rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_ICD_code " B01" ;
                     OpenPVSignal:has_MedDRA_code 10046543 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Urinary incontinence" ;
                     rdfs:label "urinary incontinence" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#urineAbnormal
:urineAbnormal rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "F1520" ;
               OpenPVSignal:has_MedDRA_code 10046605 ;
               OpenPVSignal:has_MedDRA_prefered_term "Urine abnormal" ;
               rdfs:label "urine abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#valsartan
:valsartan rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C09CA03" ,
                                     "C09DA03" ,
                                     "C09DB01" ,
                                     "C09DB08" ,
                                     "C09DX01" ,
                                     "C09DX02" ,
                                     "C09DX04" ,
                                     "C10BX10" ;
           rdfs:label "valsartan" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#verapamil
:verapamil rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C08DA01" ,
                                     "C08DA51" ,
                                     "C09BB10" ;
           rdfs:label "verapamil" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#visionAbnormal
:visionAbnormal rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:refers_to_adverse_effect :amblyopia ,
                                                      :asthenopia ,
                                                      :depthPerceptionDifficulty ,
                                                      :metamorphopsia ,
                                                      :refractiveError ,
                                                      :tiredEye ,
                                                      :visionAbnormalAggravated ,
                                                      :visionBlurred ,
                                                      :visionDecreased ,
                                                      :visualDisturbance ,
                                                      :visualImpairment ,
                                                      :visual_acquity_alteration ;
                OpenPVSignal:has_ICD_code "H53.9" ,
                                          "H54" ;
                OpenPVSignal:has_MedDRA_code 10047508 ;
                OpenPVSignal:has_MedDRA_prefered_term "Vision abnormal" ;
                rdfs:label "vision abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#visionAbnormalAggravated
:visionAbnormalAggravated rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Adverse_Effect ;
                          OpenPVSignal:has_ICD_code "H54" ,
                                                    "H54.7" ;
                          OpenPVSignal:has_MedDRA_code 10047509 ;
                          OpenPVSignal:has_MedDRA_prefered_term "Vision abnormal aggravated" ;
                          rdfs:label "vision abnormal aggravated" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#visionBlurred
:visionBlurred rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "H53.8" ;
               OpenPVSignal:has_MedDRA_code 10047513 ;
               OpenPVSignal:has_MedDRA_prefered_term "Vision blurred" ;
               rdfs:label "vision blurred" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#visionDecreased
:visionDecreased rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "H54" ,
                                           "H54.7" ;
                 OpenPVSignal:has_MedDRA_code 10047516 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Vision decreased" ;
                 rdfs:label "vision decreased" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#vision_abnormal_pathophysiology
:vision_abnormal_pathophysiology rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Free_text_reporting_element ;
                                 OpenPVSignal:refers_to_adverse_effect :visionAbnormal ;
                                 mp:references :Ref.2 ;
                                 OpenPVSignal:has_content "Vision abnormal is a non-specific term which refers to a change, usually a deterioration, in visual function or perception.2 In WHO-ART, vision abnormal is a preferred term (PT) which encompasses many included terms (ITs) consisting of amblyopia (reduced vision in an apparently normal eye), asthenopia (eye strain), depth perception difficulty, metaporphopsia (a specific type of distorted vision), refractive error, tired eye, vision abnormal, vision abnormal aggravated, vision blurred, vision decreased, visual acuity alteration, visual disturbance and visual impairment." ;
                                 rdfs:label "vision abnormal pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#visualDisturbance
:visualDisturbance rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "H53.9" ,
                                             "H54" ;
                   OpenPVSignal:has_MedDRA_code 10047543 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Visual disturbance" ;
                   rdfs:label "visual disturbance" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#visualFieldDefect
:visualFieldDefect rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "H53.4" ;
                   OpenPVSignal:has_MedDRA_code 10047555 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Visual field defect" ;
                   rdfs:label "visual field defects" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#visualImpairment
:visualImpairment rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "H54" ,
                                            "H54.7" ;
                  OpenPVSignal:has_MedDRA_code 10047571 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Visual impairment" ;
                  rdfs:label "visual impairment" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#visual_acquity_alteration
:visual_acquity_alteration rdf:type owl:NamedIndividual ,
                                    OpenPVSignal:Adverse_Effect ;
                           OpenPVSignal:has_MedDRA_code 10049061 ;
                           OpenPVSignal:has_MedDRA_prefered_term "Visual acuity decreased" ;
                           rdfs:label "visual acuity alteration" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#vitamin_B_complex
:vitamin_B_complex rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Drug ;
                   OpenPVSignal:has_ATC_code "A11EA" ;
                   rdfs:label "vitamin B complex" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#vitamins
:vitamins rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "A11" ,
                                    "B05XC" ;
          rdfs:label "vitamins" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#vitaminsWithMinerals
:vitaminsWithMinerals rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Drug ;
                      OpenPVSignal:has_ATC_code "A11JB" ;
                      rdfs:label "vitamins with minerals" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#vitreousFloaters
:vitreousFloaters rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "H43.399" ;
                  OpenPVSignal:has_MedDRA_code 10047654 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Vitreous floaters" ;
                  rdfs:label "vitreous floaters" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#vitreousHaemorrhage
:vitreousHaemorrhage rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_MedDRA_code 10047655 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Vitreous haemorrhage" ;
                     rdfs:label "vitreous haemorrhage" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#vomiting
:vomiting rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_MedDRA_code 10047700 ;
          OpenPVSignal:has_MedDRA_prefered_term "Vomiting" ;
          rdfs:label "vomiting" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#warfarin
:warfarin rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "B01AA03" ;
          rdfs:label "warfarin" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#weightDecrease
:weightDecrease rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "R63.4" ;
                OpenPVSignal:has_MedDRA_code 10047895 ;
                OpenPVSignal:has_MedDRA_prefered_term "Weight decreased" ;
                rdfs:label "weight decrease" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#weightIncrease
:weightIncrease rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "R635" ;
                OpenPVSignal:has_MedDRA_code 10047899 ;
                OpenPVSignal:has_MedDRA_prefered_term "Weight increased" ;
                rdfs:label "weight increase" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#wheezing
:wheezing rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R062" ;
          OpenPVSignal:has_MedDRA_code 10047924 ;
          OpenPVSignal:has_MedDRA_prefered_term "Wheezing" ;
          rdfs:label "wheezing" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#zinc
:zinc rdf:type owl:NamedIndividual ,
               OpenPVSignal:Drug ;
      OpenPVSignal:has_ATC_code "A16AX05" ,
                                "B05XA12" ,
                                "C05AX04" ;
      rdfs:label "zinc" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#benazeprilhydrochloride/amlodipine
<http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#benazeprilhydrochloride/amlodipine> rdf:type owl:NamedIndividual ,
                                                                                                                     OpenPVSignal:Drug ;
                                                                                                            OpenPVSignal:has_ATC_code "C08GA02" ;
                                                                                                            rdfs:label "benazepril hydrochloride/amlodipine" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#colecalciferol/calciumCarbonate
<http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#colecalciferol/calciumCarbonate> rdf:type owl:NamedIndividual ,
                                                                                                                  OpenPVSignal:Drug ;
                                                                                                         OpenPVSignal:has_ATC_code "A12AX " ;
                                                                                                         rdfs:label "colecalciferol/calcium carbonate" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hydrochlorothiazide/Triamterene
<http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hydrochlorothiazide/Triamterene> rdf:type owl:NamedIndividual ,
                                                                                                                  OpenPVSignal:Drug ;
                                                                                                         OpenPVSignal:has_ATC_code "C03DB02" ;
                                                                                                         rdfs:label "hydrochlorothiazide/ triamterene" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hydrochlorothiazide/lisinopril
<http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#hydrochlorothiazide/lisinopril> rdf:type owl:NamedIndividual ,
                                                                                                                 OpenPVSignal:Drug ;
                                                                                                        OpenPVSignal:has_ATC_code "C09BA03 " ;
                                                                                                        rdfs:label "hydrochlorothiazide/lisinopril" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#phenobarbital/atropine_sulfate/hyoscine_hydrobromide/hyoscyamine_sulphate
<http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#phenobarbital/atropine_sulfate/hyoscine_hydrobromide/hyoscyamine_sulphate> rdf:type owl:NamedIndividual ,
                                                                                                                                                            OpenPVSignal:Drug ;
                                                                                                                                                   OpenPVSignal:has_ATC_code "A03BA01" ,
                                                                                                                                                                             "A03BA03" ,
                                                                                                                                                                             "A03BB01" ,
                                                                                                                                                                             "A03DB04" ,
                                                                                                                                                                             "N03AA02" ,
                                                                                                                                                                             "QA03BB01" ;
                                                                                                                                                   rdfs:label "phenobarbital/atropine sulfate/hyoscine hydrobromide/hyoscyamine sulphate" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#potassiumbicarbonate/sodiumAlginate
<http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#potassiumbicarbonate/sodiumAlginate> rdf:type owl:NamedIndividual ,
                                                                                                                      OpenPVSignal:Drug ;
                                                                                                             OpenPVSignal:has_ATC_code "A12BA04" ;
                                                                                                             rdfs:label "potassium bicarbonate/sodium alginate" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#reportsWithrecovering/recoveredAsOutcome
<http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#reportsWithrecovering/recoveredAsOutcome> rdf:type owl:NamedIndividual ,
                                                                                                                           OpenPVSignal:Reports_group ;
                                                                                                                  OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#reportsWithrecovering/recoveredAsOutcome> ;
                                                                                                                  OpenPVSignal:has_count 12 ;
                                                                                                                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                  OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
                                                                                                                  rdfs:label "reports with recovering/recovered after withdrawl" .


###  http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#reports_with_recovering/recovered_without_withdrawl
<http://purl.org/OpenPVSignal/Signals/2014_6_dronedarone_polyneuropathy#reports_with_recovering/recovered_without_withdrawl> rdf:type owl:NamedIndividual ,
                                                                                                                                      OpenPVSignal:Reports_group ;
                                                                                                                             OpenPVSignal:is_subgroup_of :OverallReportsInVigibaseForDronedaroneAndVisionAbnormal ;
                                                                                                                             OpenPVSignal:has_count 3 ;
                                                                                                                             OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                             OpenPVSignal:refers_to_outcome_after_action "recovery without drug withdrawal" ;
                                                                                                                             rdfs:label "reports with recovering/recovered without withdrawl" .


#################################################################
#    Annotations
#################################################################

:acetylsalicylicAcid OpenPVSignal:has_ATC_code "M01BA03" ,
                                               "N02BA01" ,
                                               "B01AC06" ,
                                               "N02BA51" ,
                                               "A01AD05" ,
                                               "B01AC56" ,
                                               "N02BA71" ,
                                               "C10BX06" ;
                     rdfs:label "acetylsalicylic acid" ;
                     OpenPVSignal:has_ATC_code "C10BX08" ,
                                               "C10BX02" ,
                                               "C10BX05" ,
                                               "C10BX04" ,
                                               "C10BX01" .


###  Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi
